US20080249519A1 - Method and apparatus for applying energy to biological tissue including the use of tumescent tissue compression - Google Patents
Method and apparatus for applying energy to biological tissue including the use of tumescent tissue compression Download PDFInfo
- Publication number
- US20080249519A1 US20080249519A1 US12/140,219 US14021908A US2008249519A1 US 20080249519 A1 US20080249519 A1 US 20080249519A1 US 14021908 A US14021908 A US 14021908A US 2008249519 A1 US2008249519 A1 US 2008249519A1
- Authority
- US
- United States
- Prior art keywords
- vein
- electrode
- electrodes
- treatment site
- energy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00084—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22038—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with a guide wire
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00404—Blood vessels other than those in or around the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/124—Generators therefor switching the output to different electrodes, e.g. sequentially
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1246—Generators therefor characterised by the output polarity
- A61B2018/1253—Generators therefor characterised by the output polarity monopolar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1246—Generators therefor characterised by the output polarity
- A61B2018/126—Generators therefor characterised by the output polarity bipolar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1475—Electrodes retractable in or deployable from a housing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/378—Surgical systems with images on a monitor during operation using ultrasound
- A61B2090/3782—Surgical systems with images on a monitor during operation using ultrasound transmitter or receiver in catheter or minimal invasive instrument
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2218/00—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2218/001—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
- A61B2218/002—Irrigation
Definitions
- the invention relates generally to a method and apparatus for applying energy to shrink a hollow anatomical structure, such as a fallopian tube or a vein, including but not limited to, superficial and perforator veins, hemorrhoids, and esophageal varices.
- a method for compressing an anatomical structure prior to the application of energy and apparatus including an electrode device having multiple leads for applying energy to the compressed structure to cause it to durably assume its compressed form.
- the human venous system of the lower limbs consists essentially of the superficial venous system and the deep venous system with perforating veins connecting the two systems.
- the superficial system includes the long or great saphenous vein and the short saphenous vein.
- the deep venous system includes the anterior and posterior tibial veins which unite to form the popliteal vein, which in turn becomes the femoral vein when joined by the short saphenous vein.
- the venous system contains numerous one-way valves for directing blood flow back to the heart such as those valves 20 located in the vein 22 shown in FIG. 1 .
- the arrow leading out the top of the vein represents the antegrade flow of blood back to the heart.
- Venous valves are usually bicuspid valves, with each cusp 24 forming a sack or reservoir 26 for blood which, under retrograde blood pressure, forces the free surfaces of the cusps together to prevent retrograde flow of the blood and allows only antegrade blood flow to the heart.
- Competent venous valves prevent retrograde flow as blood is pushed forward through the vein lumen and back to the heart.
- FIG. 2 A cross-sectional perspective view of a dilated vein with an incompetent valve 28 taken along lines 2 - 2 of FIG. 1 is illustrated in FIG. 2 .
- valve cusps 24 can experience some separation at the commissure due to the thinning and stretching of the vein wall at the cusps.
- Two venous conditions which often result from valve failure are varicose veins and more symptomatic chronic venous insufficiency.
- the varicose vein condition includes dilation and tortuosity of the superficial veins of the lower limbs, resulting in unsightly discoloration, pain, swelling, and possibly ulceration.
- Varicose veins often involve incompetence of one or more venous valves, which allow reflux of blood within the superficial system. This can also worsen deep venous reflux and perforator reflux.
- Current treatments of vein insufficiency include surgical procedures such as vein stripping, ligation, and occasionally, vein-segment transplant.
- Chronic venous insufficiency involves an aggravated condition of varicose veins which may be caused by degenerative weakness in the vein valve segment, or by hydrodynamic forces acting on the tissues of the body, such as the legs, ankles, and feet.
- the hydrostatic pressure increases on the next venous valves down, causing those veins to dilate.
- more venous valves will eventually fail.
- the effective height of the column of blood above the feet and ankles grows, and the weight and hydrostatic pressure exerted on the tissues of the ankle and foot increases.
- ulcerations of the ankle begin to form, which start deep and eventually come to the surface. These ulcerations do not heal easily because of poor venous circulation due to valvular incompetence in the deep venous system and other vein systems.
- Other related venous conditions include dilated hemorrhoids and esophageal varices. Pressure and dilation of the hemorrhoid venous plexus may cause internal hemorrhoids to dilate and/or prolapse and be forced through the anal opening. If a hemorrhoid remains prolapsed, considerable discomfort, including itching and bleeding, may result. The venous return from these prolapsed hemorrhoids becomes obstructed by the anal sphincters, which gives rise to a strangulated hemorrhoid. Thromboses result where the blood within the prolapsed vein becomes clotted. This extremely painful condition can cause edema and inflammation.
- Varicose veins called esophageal varices can form in the venous system with submucosa of the lower esophagus, and bleeding can occur from the dilated veins. Bleeding or hemorrhaging may result from esophageal varices, which can be difficult to stop and, if untreated, could develop into a life threatening condition. Such varices erode easily, and lead to a massive gastrointestinal hemorrhage.
- Ligation of a fallopian tube for sterilization or other purposes is typically performed by laparoscopy.
- a doctor severs the fallopian tube or tubes and ties the ends.
- External cauterization or clamps may also be used.
- General or regional anesthetic must be used. All of the above are performed from outside the fallopian tube.
- ligation or “intra-luminal ligation” comprises the occlusion, collapse, or closure of a lumen or hollow anatomical structure by the application of energy from within the lumen or structure.
- ligation or “intra-luminal ligation” includes electro-ligation. In the case of fallopian tube ligation, it would be desirable to perform the ligation from within the fallopian tube itself (intra-fallopian tube) to avoid the trauma associated with external methods.
- Ligation involves the cauterization or coagulation of a lumen using energy, such as that applied through an electrode device.
- An electrode device is introduced into the lumen and positioned so that it contacts the lumen wall. Once properly positioned, RF energy is applied to the wall by the electrode device thereby causing the wall to shrink in cross-sectional diameter.
- a reduction in cross-sectional diameter of the vein as for example from 5 mm (0.2 in) to 1 mm (0.04 in), significantly reduces the flow of blood through a lumen and results in an effective occlusion.
- the vein wall may completely collapse thereby resulting in a full-lumen obstruction that blocks the flow of blood through the vein.
- a fallopian tube may collapse sufficiently to effect a sterilization of the patient.
- One apparatus for performing ligation includes a tubular shaft having an electrode device attached at the distal tip.
- the leads terminate at an electrical connector, while at the distal end of the shaft the leads are connected to the electrode device.
- the electrical connector provides the interface between the leads and a power source, typically an RF generator.
- the RF generator operates under the guidance of a control device, usually a microprocessor.
- the ligation apparatus may be operated in either a monopolar or bipolar configuration.
- the electrode device consists of an electrode that is either positively or negatively charged.
- a return path for the current passing through the electrode is provided externally from the body, as for example by placing the patient in physical contact with a large low-impedance pad. The current flows between the ligation device and low impedance pad through the patient.
- the electrode device In a bipolar configuration, the electrode device consists of a pair of electrodes having different potentials (such as a pair of oppositely-charged electrodes) of approximately equal size, separated from each other, such as by a dielectric material or by a spatial relationship. Accordingly, in the bipolar mode, the return path for current is provided by an electrode or electrodes of the electrode device itself. The current flows from one electrode, through the tissue, and returns by way of another electrode.
- a temperature sensing device is typically attached to the electrode device, although it may be located elsewhere.
- the temperature sensing device may be a thermocouple that monitors the temperature of the venous tissue.
- the thermocouple interfaces with the RF generator and the controller through the shaft and provides electrical signals to the controller which monitors the temperature and adjusts the energy applied to the tissue through the electrode device accordingly.
- a fixed-size electrode device typically contacts the vein wall at only one point or a limited arc on the circumference or inner diameter of the vein wall.
- RF energy is highly concentrated within the contacting venous tissue, while the flow of RF current through the remainder of the venous tissue is disproportionately weak. Accordingly, the regions of the vein wall near the area of contact collapse at a faster rate than other regions of the vein wall, resulting in non-uniform shrinkage of the vein lumen.
- the overall strength of the occlusion may be inadequate and the lumen may eventually reopen.
- RF energy must be applied for an extended period of time so that the current flows through the tissue, including through the tissue not in contact with the electrode, generating thermal energy and causing the tissue to shrink sufficiently.
- Extended applications of energy have a greater possibility of increasing the temperature of the blood to an unacceptable level and may result in a significant amount of heat-induced coagulum forming on the electrode and in the vein which is not desirable.
- exsanguination comprises the removal of all or some significant portion of blood in a particular area.
- the effectiveness of a ligating apparatus having a fixed-size electrode device is limited to certain sized veins.
- An attempt to ligate a vein having a diameter that is substantially greater than the fixed-size electrode device can result in not only non-uniform heating of the vein wall as just described, but also insufficient shrinkage of the vein diameter.
- the greater the diameter of the vein relative to the diameter of the electrode device the weaker the energy applied to the vein wall at points distant from the point of electrode contact.
- larger diameter veins must shrink a larger percentage for effective occlusion to occur. Accordingly, the vein wall is likely to not completely collapse prior to the venous tissue becoming over-cauterized at the point of electrode contact.
- a technique of reducing the diameter of the lumen of a vein at least close to the final desired diameter before applying energy to the vein has been found to aid in the efficiency of these types of procedures.
- the pre-reduction in vein diameter assists in pre-shaping the vein to be molded into a ligated state.
- the compression also exsanguinates the vein and forces blood away from the treatment site, thus preventing coagulation.
- One valuable technique employed is that of compressing the vein contained within a limb by applying external hydraulic pressure, via a pressure tourniquet, to the limb.
- a pressure tourniquet Unfortunately there are some areas of the body to which a pressure tourniquet cannot be applied, such as the sapheno-femoral junction, which is above the thigh proximate the groin area.
- there are sites where a pressure tourniquet may be ineffective such as: the popliteal junction and other areas around the knee; and the ankle area (typically the posterior arch vein and some of the lower cockett perforators).
- tumescent anesthesia there exists a technique referred to as tumescent anesthesia that has been used in connection with liposuction procedures.
- the word “tumescent” means swollen or firm. This technique is accomplished by subcutaneously delivering into target fatty tissue a large volume of saline solution containing diluted Lidocaine and Epinephrine (adrenaline), a vasoconstrictive drug. The injected area then becomes locally anesthetized, and the adrenaline temporarily constricts the capillaries and other blood vessels.
- the tumescence-inducing fluid, or “tumescent fluid” is injected under pressure which causes the target fatty tissue to become swollen and firm.
- the tumescent fluid is typically pumped into the pocket of fat in order to numb the area, loosen the fat, and constrict the blood vessels to minimize bleeding or bruising in a liposuction procedure.
- the anesthetic and other agents in the tumescent solution should be allowed sufficient time to diffuse and take full effect throughout the target tissue. After surgery, patients may leave without assistance, and often return to their regular routine within several days. With the tumescent technique, postoperative discomfort is significantly reduced. The local anesthesia often remains in the treated tissue for 16 hours after surgery. Employing a technique of utilizing tumescent anesthesia in conjunction with ligation or radial lumen shrinkage less than ligation may provide benefits.
- the present invention is directed to a method and apparatus for applying energy to a hollow anatomical structure such as a vein, to shrink the structure.
- the invention is directed to pre-compressing and exsanguinating a hollow anatomical structure while providing anesthetic and insulation benefits during a procedure of shrinking the hollow anatomical structure.
- a method comprises providing fluid to tissue surrounding a hollow anatomical structure to induce tumescence of the tissue and consequent compression of the hollow anatomical structure during a procedure of applying energy to the hollow anatomical structure from within the structure.
- the method comprises introducing into the hollow anatomical structure a catheter having a working end and at least one electrode at the working end; placing the electrode into contact with the inner wall of the pre-compressed hollow anatomical structure and applying energy to the hollow anatomical structure at the treatment site via the electrode until the hollow anatomical structure durably assumes dimensions less than or equal to the pre-compressed dimensions caused by the injection of the solution into the tissue.
- tumescent fluid is injected in the tissue surrounding the hollow anatomical structure along a selected length of the hollow anatomical structure.
- the electrode is then moved along a site within the selected length while continuously applying energy to result in a lengthy occlusion.
- the electrode is moved down a given length of the hollow anatomical structure and energy is applied at that adjacent site.
- the hollow anatomical structure durably assumes dimensions less than or equal to the pre-compressed dimensions caused by the injection of the solution into the tissue.
- tumescent anesthesia fluid is injected or otherwise provided to tissue contiguous with a vein to compress the vein to about a desired final diameter.
- a catheter having an energy application device, such as expandable electrodes, is introduced internal to the vein at a site within the compressed portion of the vein and energy is applied to the internal vein wall by the application device. Sufficient energy is applied to cause the vein to durably assume the compressed diameter such that when the effects of the tumescent anesthesia fluid are dissipated, the vein retains the compressed diameter.
- Alternate means to prevent coagulum formation include fluid displacement of blood at the treatment site, or exsanguination by inducing self-constriction of the vessel.
- self-constriction includes, but is not limited to, intraluminal delivery of a vasoconstrictive drug. Self-constriction also aids in pre-shaping the vein for ligation, as discussed previously. If the fluid delivered to the site is a sclerosant, the ligation effects would be further enhanced.
- energy is applied to effectively occlude the treatment site.
- the energy application device is moved along the treatment site while performing the step of applying energy so as to result in a lengthy occlusion of the treatment site.
- the treatment site may collapse around the energy application device as it is being moved.
- fluid is delivered from within the hollow structure to the treatment site. This fluid may be used to exsanguinate the treatment site.
- Such fluid may be from the following group: saline; a vasoconstrictive agent; a sclerosing agent; a high impedance fluid; and heparin.
- temperatures are sensed at two separate locations on the energy application device, and the temperature signals are averaged to determine the temperature at the site.
- electrical energy is applied to the inner wall of the treatment site with an electrode, the electrode being in apposition with the inner wall.
- the method further comprises the steps of applying electrical energy with the electrode to effectively occlude the treatment site at the electrode, and moving the electrode along the treatment site while maintaining the electrode in apposition with the vein wall while performing the step of applying energy to effectively occlude the treatment site so as to result in a lengthy effective occlusion of the treatment site.
- Sufficient energy is applied to collapse the hollow anatomical structure around the energy application device as it is being moved along the treatment site to result in a lengthy effective occlusion of the treatment site.
- apposition of the energy application device with the inner wall of the hollow anatomical structure is determined by monitoring the impedance experienced by the energy application device.
- FIG. 1 shows a cross-sectional view of a vein having competent valves and having a dilated section with incompetent venous valves in a lower limb which are to be treated in accordance with the present invention
- FIG. 2 shows a representative view of a venous section with an incompetent valve from FIG. 1 taken along line 2 - 2 which is to be treated in accordance with the present invention
- FIG. 3 is a cross-sectional view of the vein of FIG. 1 after the vein has been compressed, although not to full occlusion, by the injection of a tumescent anesthesia fluid in tissue surrounding the vein showing a catheter including an expandable electrode device prior to the application of energy to the vein;
- FIG. 4 is a diagram of an energy application system that may be used in conjunction with the method of the present invention, depicting a partial cutaway view of the first embodiment of the catheter showing both the working end and the connecting end with an RF generator and a microprocessor connected at the connection end;
- FIG. 5 is a cross-sectional view of the working end of an embodiment of a catheter in accordance with the invention depicting the electrodes in a fully retracted position;
- FIG. 5 a is an end view of the working end of the embodiment of the catheter taken along line 5 a - 5 a of FIG. 5 ;
- FIG. 6 is a cross-sectional view of the working end of the embodiment of the catheter of FIGS. 5 and 5 a depicting the electrodes in a fully expanded position;
- FIG. 6 a is an end view of the working end of the embodiment of the catheter taken along line 6 a - 6 a of FIG. 6 ;
- FIG. 7 is a cross-sectional view of a vein after the vein has been compressed, although not to full occlusion, by tumescent anesthesia fluid, the vein containing the catheter of FIG. 5 with the electrodes in apposition with the vein;
- FIG. 8 is a cross-sectional view of the compressed vein containing the catheter of FIG. 5 where the vein is being ligated by the application of energy from the electrodes;
- FIG. 9 is a partial cross-sectional view of the vein wall of FIG. 8 showing a lengthy effective occlusion made by moving the electrodes along the treatment site of the vein while maintaining the electrodes in apposition and continuing to apply energy to the vein wall.
- FIG. 10 is a side view of an embodiment of an electrode catheter having two pluralities of longitudinally-separated expandable electrodes in a retracted condition
- FIG. 11 is a side view of the embodiment of the electrode catheter of FIG. 10 with both pluralities of the electrodes in expanded configurations;
- FIG. 12 is a partial cross-sectional view of the embodiment of an electrode catheter of FIGS. 10 and 11 .
- the invention is directed toward the intravenous treatment of veins using a catheter to deliver at least one electrode to a venous treatment site.
- like reference numerals will designate similar elements in the various embodiments of the present invention to be discussed.
- the term “working end” will refer to the direction toward the treatment site in the patient, and the term “connecting end” will refer to the direction away from the treatment site in the patient. The invention will be described in relation to the treatment of the venous system of the lower limbs.
- the invention is not limited thereto and may be employed intraluminally to treat veins in other areas of the body such as hemorrhoids, esophageal varices, and venous-drainage-impotence of the penis.
- the invention will be described as using RF energy from the electrode, it is to be understood that other forms of energy such as microwaves, ultrasound, direct current, circulating heated fluid, radiant light, and lasers can be used, and that the thermal energy generated from a resistive coil or Curie point element may be used as well.
- one preferred method of the present invention can be performed using the catheter 30 to deliver an expandable electrode device 32 (partially shown) to a venous treatment site in order to ligate the vein.
- an expandable electrode device 32 partially shown
- a tumescent anesthesia technique can be used to inject a dilute anesthetic and vasoconstrictive solution into the tissue surrounding the vein to be treated.
- the tumescent solution preferably includes mostly saline solution, with a local anesthetic such as Lidocaine, and a vasoconstrictive drug such as Epinephrine.
- the tumescent solution causes the surrounding tissue 34 to become swollen which compresses the vein 22 , as indicated by the arrows, dose to occlusion (in this case) or to occlusion. Sufficient tumescent solution should be delivered into the tissue surrounding the vein to compress and exsanguinate the vein.
- the catheter 30 is placed within the vein at the treatment site, with the expandable electrode device retracted.
- the solution is typically infused with a peristaltic pump. However, 60 cc or 100 cc syringes 35 can be used.
- Another alternative is an IV bag with a pressure cuff. Large volumes are typically delivered into the perivenal area via a large cannula. Sites are typically located 10 cm apart down the leg. Usually there are four or five delivery sites. The external result is a leg that appears inflated. The internal result is compressed veins plus an anesthetized leg.
- the expandable electrode device is then expanded into apposition with the venous tissue after compression of the vein. Energy such as high frequency RF energy is applied from the expandable electrode device to the venous tissue until the vein durably assumes dimensions less than or equal to the compressed dimensions caused by the injection of the tumescent solution into the tissue.
- the electrode may be retracted and the catheter moved to another venous section where the ligation process is repeated. Ultrasound guidance can be used to monitor the progress of the procedure.
- the catheter 30 includes an expandable energy application device 56 which in this embodiment, comprises an array of electrodes 58 , an outer sheath 36 having a distal orifice 38 at its working end 40 .
- the connector end 42 of the outer sheath is attached to a handle 44 that includes electrical connector 46 .
- the handle additionally includes a guide wire port 48 .
- the connector 46 is for interfacing with a power source, typically an RF generator 50 , and a microprocessor controller 52 .
- the power source and microprocessor controller are usually contained in one unit.
- the microprocessor controller controls the RF generator in response to external commands and data from a temperature sensor 54 , such as a thermocouple, or temperature sensors that may be positioned at an intraluminal venous treatment site.
- the catheter 30 includes the expandable electrode device 56 that moves in and out of the outer sheath by way of the distal orifice 38 in this embodiment, although in other embodiments the device 56 may expand from and contract into the catheter 30 at other locations.
- the expandable electrode device 56 includes a plurality of electrodes 58 which can be expanded by moving the outer sheath 36 relative to the electrodes.
- FIG. 4 illustrates a plurality of electrodes 58 surrounding a single central electrode, different electrode configurations may be used.
- a fluid port 62 communicates with the interior of the outer sheath.
- the catheter 30 can be periodically flushed out with saline through the fluid port.
- the flushing fluid can travel between the outer sheath and the inner sheath.
- the fluid port also allows for the delivery of drug therapies. Flushing out the catheter prevents the buildup of biological fluid, such as blood, within the catheter.
- the treatment area or site of the vein can be flushed with a fluid such as saline, or a high impedance dielectric fluid, in order to evacuate blood from the treatment area of the vein so as to prevent the formation of coagulum or thrombosis.
- a high impedance dielectric fluid can minimize unintended heating effects away from the treatment area.
- the dielectric fluid directs the current of RF energy toward the vein wall.
- a vasoconstrictive agent may be applied to shrink the vein
- heparin may be applied for coagulation avoidance
- a sclerosing agent may be applied to assist in ligation.
- the catheter 30 includes a lumen which begins at the distal tip 55 , proximate the working end 40 , and runs substantially along the axis of the inner member before terminating at the guide wire port 48 of the handle 44 .
- a guide wire can be introduced through the lumen of the catheter for use in guiding the catheter to the desired treatment site.
- the catheter is sized to treat smaller veins, the outer diameter of the catheter may not allow for a fluid flush between the outer sheath and the inner sheath 60 . However, a fluid flush can be introduced through the guide wire port 48 in such an embodiment.
- an actuator 76 controls the extension of the electrode device 56 through the distal orifice 38 .
- the actuator may take the form of a switch, lever 78 , threaded control knob, or other suitable mechanism, and is preferably one that can provide fine control over the movement of the outer sheath 36 or the inner sheath 60 , as the case may be.
- the actuator interfaces with the outer sheath to move it back and forth relative to the inner sheath.
- the actuator interfaces with the inner sheath to move it back and forth relative to the outer sheath. The relative position between the outer sheath and inner sheath is thus controlled, but other control approaches may be used.
- FIG. 5 A preferred embodiment of a catheter 90 is illustrated in FIG. 5 .
- An inner member 92 or sheath is contained within the outer sheath 94 .
- the inner sheath is preferably constructed from a flexible polymer such as polymide, polyethylene, or nylon, and can travel the entire length of the catheter. The majority of the catheter should be flexible so as to navigate the tortuous paths of the venous system.
- a hypotube having a flared distal end 98 and a circular cross-sectional shape is attached over the distal end of the inner sheath 92 .
- the hypotube 96 is preferably no more than about two to three centimeters in length.
- the hypotube acts as part of a conductive secondary lead 100 .
- An uninsulated conductive electrode sphere 102 is slipped over the hypotube.
- the flared distal end of the hypotube prevents the electrode sphere from moving beyond the distal end of the hypotube.
- the sphere is permanently affixed to the hypotube, such as by soldering the sphere both front and back on the hypotube.
- the majority of the surface of the electrode sphere remains uninsulated.
- the remainder of the hypotube is preferably insulated so that the sphere-shaped distal end can act as the electrode.
- the hypotube can be covered with an insulating material such as a coating of parylene.
- the interior lumen of the hypotube is lined by the inner sheath 92 which is attached to the flared distal end of the hypotube by adhesive such as epoxy.
- the secondary lead 100 Surrounding the secondary lead 100 are a plurality of primary leads 104 that preferably have a flat rectangular strip shape and can act as arms.
- the strip shape is a width from 0.76 mm (0.03 in) to 1.00 mm (0.04 in) and a thickness of approximately 0.13 mm (0.005 in.).
- the plurality of primary leads 104 is preferably connected to common conductive rings 106 . This configuration maintains the position of the plurality of primary leads, while reducing the number of internal electrical connections.
- the conductive rings 106 are attached to the inner sheath 92 . The position of the rings and the primary leads relative to the outer sheath 94 follows that of the inner sheath.
- the hypotube 96 of the secondary lead is also attached to the inner sheath.
- Two separate conductive rings can be used so that the polarity of different primary leads can be controlled separately.
- adjacent primary leads can be connected to one of the two separate conductive rings so that the adjacent leads can be switched to have either opposite polarities or the same polarity.
- the rings are preferably spaced closely together, but remain electrically isolated from each other along the inner sheath. Both the rings and the hypotube are coupled with the inner sheath, and the primary leads that are connected to the rings move together with the secondary lead while remaining electrically isolated from the secondary lead. Epoxy or another suitable adhesive can be used to attach the rings to the inner sheath.
- FIG. 6 a illustrates an end view of the working end of catheter 90 taken along line 6 a - 6 a of FIG. 6 .
- the conductive rings 106 and the primary leads 104 are attached together to act as cantilevers where the ring forms the base and the rectangular primary leads operate as the cantilever arms.
- the primary leads are formed to have an arc or bend such that the primary leads act as arms that tend to spring outwardly away from the catheter 90 and toward the surrounding venous tissue. Insulation along the underside of the primary leads and the conductive rings prevents unintended electrical coupling therebetween.
- the primary leads are formed straight and connected to the conductive rings at an angle such that the primary leads tend to expand or spring radially outward from the conductive rings.
- the angle at which the primary leads are attached to the conductive rings should be sufficient to force the primary distal ends and their electrodes 108 through blood and into apposition with the vein wall 80 but not enough to preclude vein shrinkage.
- the primary leads 104 are formed with enough strength, and are mounted or bent such that they expand outwardly into apposition with the inner wall of the vein.
- the force they develop in an outward direction is not strong enough to prevent radial shrinkage of the vein.
- the shrinking vein causes a contraction of the primary electrodes. Due to the outward force constantly exerted by the primary leads 104 , the electrodes 108 remain in constant apposition with the vein wall as it shrinks.
- the rectangular cross section of the primary leads can provide increased stability in the lateral direction while allowing the necessary bending in the radial direction.
- the primary leads are less likely to bend sideways when expanded outward due to the increased size of the rectangular lead in that sideways direction, and a uniform spacing between primary leads is more assured. Uniform spacing between the primary leads and the distal ends promotes uniform heating around the vein by the electrodes 108 .
- the distal ends of the primary leads 104 are uninsulated to act as the electrodes 108 having a rounded shape.
- the shape is convex which may take the form of a spoon or hemispherical shape.
- the primary leads can be stamped to produce an integral shaped electrode at the distal end of the primary leads.
- the uninsulated outer portion of the distal end of the electrodes 108 which are to come into apposition with the wall of the vein is preferably rounded and convex.
- the flattened or non-convex inner portion of the distal end is insulated to minimize any unintended thermal effect, such as on the surrounding blood in a vein.
- the distal ends of the electrodes 108 are configured such that when the distal ends are forced toward the inner sheath 92 , as shown in FIG. 5 a , the distal ends combine to form a substantially spherical shape with a profile smaller than the spherical electrode 102 at the secondary distal end.
- the electrodes 108 comprise a convex, square center section with semi-circular ends. It has been found that this “race track” configuration maximizes surface area of contact for the electrodes 108 shown.
- the outer sheath 94 can slide over and surround the primary and secondary leads 100 and 104 .
- the outer sheath includes an orifice 110 which is dimensioned to have approximately the same size as the spherical electrode 102 at the secondary distal end. A close or snug fit between the spherical electrode 102 and the orifice 110 of the outer sheath is achieved. This configuration provides an atraumatic tip for the catheter 90 .
- the spherical electrode 102 is preferably slightly larger than the orifice 110 .
- the inner diameter of the outer sheath is approximately the same as the diameter of the reduced profile of the combined primary distal end electrodes 108 .
- a fluid port can communicate with the interior of the outer sheath 94 so that fluid can be flushed between the outer sheath and inner sheath 92 as described above.
- a fluid port can communicate with a central lumen 112 in the hypotube which can also accept a guide wire for use in guiding the catheter to the desired treatment site.
- another lumen can be formed in the catheter to deliver fluid to the treatment site.
- the delivered fluid displaces or exsanguinates blood from the vein so as to avoid heating and coagulation of blood.
- the delivery of a dielectric fluid increases the surrounding impedance so that RF energy is directed into the tissue of the vein wall.
- An alternate fluid could be a sclerosing agent which could serve to displace blood or to further enhance occlusion of the vein when applied before, during, or after energy delivery.
- the fluid can also include an anticoagulant such as heparin which can chemically discourage the coagulation of blood at the treatment site.
- the catheter 90 can be periodically flushed with saline which can prevent the buildup of biological fluid, such as blood, within the catheter.
- the saline can be flushed through the central lumen 112 or between the inner and outer sheaths. If a central lumen is not desired, the lumen of the hypotube can be filled with solder.
- the electrode device 114 can operate in either a bipolar or a monopolar configuration. When adjacent primary leads have opposite polarity, a bipolar electrode operation is available. When the primary leads are commonly charged a monopolar electrode operation is available in combination with a large return electrode pad placed in contact with the patient. When the primary electrodes 108 are commonly charged or have a first potential, and a secondary electrode 102 has an opposite polarity or different potential, a bipolar electrode operation is available. More or fewer leads may be used. The number of leads can be dependent on the size or diameter of the vein to be treated, as described above.
- the catheter 90 can include one or more temperature sensors, such as thermocouples, mounted in place on an electrode 108 so that the sensor is substantially flush with the exposed surface of the electrode 108 .
- the temperature sensor senses the temperature of the portion of the vein that is in apposition with the exposed electrode 108 surface.
- the sensor provides an indication of when shrinkage occurs (70 degrees C. or higher).
- Application of RF energy from the electrodes 108 is halted or reduced when the monitored temperature reaches or exceeds the specific temperature that was selected by the operator, such as the temperature at which venous tissue begins to cauterize.
- the catheter is inserted into a vein 22 .
- Fluoroscopy, ultrasound, an angioscope imaging technique, or another technique may be used to direct and confirm the specific placement of the catheter in the vein.
- Impedance measurements can also be used to determine proper positioning of the catheter, particularly at the ostium of a vessel such as at the sapheno-femoral junction. The impedance will be low when the electrodes are in the blood stream.
- the catheter can then be moved until a high impedance value is obtained, indicating electrode contact with the vein wall.
- the vein wall 80 has been compressed by the introduction of tumescent anesthesia into the tissue surrounding the vein as indicated by the arrows.
- the arrows in the figures indicate the compression of the tissue. Unless stated otherwise, all drawing figures having arrows indicating tissue compression are not drawn to scale for purposes of clarity of illustration and are meant to be representations of the vein in a nearly fully occluded state.
- the reduction in the vein 22 diameter caused by the tumescence of the tissue in contact with the treatment site assists in pre-shaping the vein to be molded to a ligated state.
- the compression also exsanguinates the vein and forces blood away from the treatment site, thus preventing coagulation.
- the actuator 76 ( FIG. 4 ) is then operated to retract the outer sheath 94 to expose leads the 100 and 104 .
- the primary leads 104 move outward relative to the axis defined by the outer sheath, while the secondary lead 100 remains substantially linear along the axis defined by the outer sheath.
- the primary leads continue to move outward until their electrodes 108 are placed in apposition with the vein wall 80 and the outward movement of the primary leads is impeded.
- the primary electrodes 108 contact the vein wall along a generally circumferential area or band of the vein wall. This outward movement of the primary leads occurs in a substantially symmetrical fashion so that the primary electrodes 108 are substantially evenly spaced.
- the electrodes 86 can be spaced apart in a staggered fashion such that they do not lie in the same plane.
- the adjacent electrodes 86 can extend different lengths from the catheter so that a smaller cross-sectional profile is achieved when the electrodes 86 are collapsed toward one another.
- the RF generator 50 is activated to provide suitable RF energy.
- suitable frequency is 510 kHz.
- One criterion used in selecting the frequency of the energy to be applied is the control desired over the spread, including the depth, of the thermal effect in the venous tissue. Another criterion is compatibility with filter circuits for eliminating RF noise from thermocouple signals.
- the primary electrodes 108 are charged with one polarity opposite that of the secondary electrode 102 . The coupling between oppositely charged primary and secondary electrodes produces RF fields therebetween, and form a symmetrical RF field pattern along a circumferential band of the vein wall 80 to achieve a uniform temperature distribution along the vein wall being treated.
- the RF energy produces a thermal effect which causes the venous tissue to shrink, reducing the diameter of the vein 22 .
- the thermal effect produces structural transfiguration of the collagen fibrils in the vein.
- the collagen fibrils shorten and thicken in cross-section in response to the heat from the thermal effect.
- the energy causes the vein wall 88 to collapse until further collapse is impeded by the primary lead electrodes 108 .
- the primary lead electrodes are pressed closer together by the shrinking vein wall and assume a reduced profile shape which is sufficiently small so that the vein is effectively ligated.
- the catheter 90 is pulled back while continuing energy delivery as shown in FIG. 9 .
- Ligation as the catheter is being retracted produces a lengthy occlusion 89 which is stronger and less susceptible to recanalization than an acute point occlusion.
- the secondary-lead electrode 102 In a monopolar operation, the secondary-lead electrode 102 remains neutral, while the primary electrodes 108 are commonly charged and act in conjunction with an independent electrical device, such as a large low-impedance return pad (not shown) placed in external contact with the body, to form RF fields substantially evenly spaced around the circumference of the vein.
- an independent electrical device such as a large low-impedance return pad (not shown) placed in external contact with the body, to form RF fields substantially evenly spaced around the circumference of the vein.
- the thermal effect produced by those RF fields along the axial length of the vein wall 80 causes the vein wall to collapse around the primary lead electrodes.
- the electrode device is retracted as described in the bipolar operation.
- the application of RF energy is substantially symmetrically distributed through the vein wall, as previously described.
- the electrodes should be spaced no more than 4 or 5 millimeters apart along the circumference of the vein wall 80 , which defines the target vein diameter for a designed electrode catheter. Where the electrodes are substantially evenly spaced in a substantially symmetrical arrangement, and the spacing between the electrodes is maintained, a symmetrical distribution of RF energy increases the predictability and uniformity of the shrinkage and the strength of the occlusion.
- the primary leads may be mounted or otherwise configured such that they expand outwardly in an asymmetrical fashion.
- One purpose for an asymmetrical electrode arrangement is to only shrink a portion of the vein wall to achieve occlusion. Such may be desired in the case of preferentially shrinking a tributary branch or aneurysm on one side of the vein.
- the actuator 76 causes the primary leads 104 to return to the interior of the outer sheath 94 . Once the primary leads are within the outer sheath, the catheter 90 may be moved to another venous section where the ligation process is repeated.
- an expandable electrode catheter 118 includes two sets of expandable electrode leads 120 and 122 , although additional sets of electrode leads may be possible.
- the electrodes 124 of this embodiment are similar to the electrodes of the embodiment illustrated in FIG. 6 having electrodes with a rounded, convex, spoon-shaped contact area. Other shapes for the electrode may be used, such as ellipses, rounded, ovals, race tracks, and others. Although only one electrode is indicated by numeral 124 in FIGS. 10 and 11 , this is for purposes of clarity in the drawings only. All electrodes are meant to be indicated by numeral 124 . While each set of electrode leads may include as few as two electrode leads, the illustrated embodiment includes six electrode leads per set, although more than six electrode leads may be used as well.
- the sets of electrode leads 120 and 122 are longitudinally separated from each other.
- the electrodes within each set of electrode leads are separated from one another radially and each of those electrodes is also separated from every electrode in the other set longitudinally, due to the longitudinal separation. There therefore exists radial separation and longitudinal separation of electrodes at the working end 126 of the catheter 118 in the arrangement shown in FIGS. 10 and 11 .
- Electrodes leads With the configuration of electrode leads presented in FIGS. 10 and 11 , greater flexibility exists in establishing current flows through the tissue of a patient. As in previous embodiments, the electrodes expand outwardly into contact with patient tissue. Where all the electrodes of a first set of electrode leads have the same polarity, there may be an odd number of electrodes in the set, or an even number. All electrodes in the set may be connected to a common connection point, such as the conducting ring 106 shown in FIG. 6 . A single conductor from the connecting end of the catheter may power all electrodes of the set by a single connection to that conducting ring. All electrodes of a second set of electrode leads may also be commonly connected at a respective conducting ring but to a different electrical potential than the first set.
- a monopolar arrangement may also be established if desired by setting all electrodes of all electrode leads to the same electrical potential and establishing a different electrical potential outside the patient, such as at a “backplate” in contact with the skin of the patient at a selected location. Energy from the working end 126 of the catheter will then flow through the patient to the return provided by the backplate.
- the electrodes in the first set of electrode leads may be individually controlled so that there are electrode pairs of differing potentials in the set of leads. This would establish a bipolar approach within the first set of leads itself. If the electrodes of the second set of leads are likewise connected for different potentials among themselves, they too would provide a bipolar approach in their own set and currents would flow through patient tissue between the electrodes in each set of leads.
- Electrodes having a first polarity in the first set are aligned with the electrodes having a different polarity in the second set of leads, energy would not only flow between the bipolar electrodes within the set but would also flow to the electrodes in the other set resulting in two bipolar arrangements at the single working end of the catheter.
- Patient tissue of a length at least as great as the distance between the first and second sets of electrode leads will receive energy, as well as, patient tissue between electrodes within each set of leads itself.
- a further arrangement coupled with the bipolar approach just described would be to also use a backplate at a different electrical potential to provide further control over the energy flow through the patient's tissue.
- energy would flow between the electrodes within each set of leads, between electrodes in different sets of leads, and between electrodes and the backplate.
- each of the electrodes may be individually connected to a power source ( 50 , FIG. 4 ) and the electrical potential at each electrode can be individually controlled.
- This arrangement may yield even more precise control over the current densities through patient tissue.
- the potential between the electrodes of the same set may be reduced but the potential between those electrodes and the electrodes of the second set of leads may be increased resulting in the desired current flow densities.
- the electrodes may be controlled so that energy flows between such electrodes and the backplate. Because each electrode is individually controlled, the level of energy it imparts to the tissue at its location is controllable.
- One factor that could affect the number of electrodes per set of electrode leads is the diameter of the vein being treated.
- the design of the contact pad for the electrode leads could also affect the desired number of electrodes for a given procedure.
- the electrode leads 120 , 122 are formed to expand outwardly into apposition with the target tissue, yet as the target tissue shrinks, the electrodes maintain contact with that tissue and are moved inwardly by that tissue. Because of this arrangement, the leads compensate for variations in the diameter of the vein. They are therefore capable of maintaining apposition with the tissue whether or not compression of the vein or anatomical structure exists, such as by use of a pressure cuff or tourniquet or tumescence of the surrounding tissue.
- the tip 128 of the electrode catheter 118 should have a hemispherical or another atraumatic shape.
- the tip 128 may be electrically neutral, and may be fabricated from a polymer or it may be fabricated of stainless steel. Because the tip 128 has a rounded shape and is located at the distal extreme of the catheter, it may perform a guiding function when introducing the catheter to the patient.
- the double set of expandable electrodes can be used to ligate veins or other hollow anatomical structures in a manner similar to that previously described.
- the outer sheath 130 can be pulled back to allow the electrode to expand outwardly from the catheter and into apposition with the wall of the lumen being treated.
- the two sets of electrodes 120 and 122 apply energy to the lumen to cause it to shrink to a reduced diameter.
- the catheter can be moved or pulled back while the energy is being applied to treat an extended area of the lumen.
- the desired area of the lumen or vein is treated (e.g., ligated) energy is no longer provided to the electrodes, and the outer sheath 130 is pushed forward to force the expanded electrodes back to an unexpanded condition.
- the catheter can then be removed from the patient, or another section of the vein can be treated.
- FIG. 12 there is shown a partial cross-section view of the catheter of FIGS. 10 and 11 .
- Two pluralities of electrodes 120 and 122 are shown with the electrodes of the first plurality 120 being indicated by numeral 124 and the electrodes of the second plurality 122 being indicated by numeral 150 .
- Each electrode is formed from an electrically-conductive electrode lead 152 and 154 respectively that is electrically insulated along its length except at its distal end at which point no insulation exists thus forming the electrode.
- Each lead has an outward bend (not shown).
- An inner tube 156 includes a lumen 158 through which fluid may flow for flush or other purposes, or through which a guide wire may be positioned.
- a hypotube 160 is positioned over the inner tube and layers of insulation 162 are mounted over the hypotube.
- the first plurality 120 of electrode leads 152 extend proximally to a first mounting ring 164 to which all are connected.
- the second plurality 122 of electrode leads 154 extend proximally to a second mounting ring 166 to which all are connected.
- the rings 164 and 166 are mounted over the hypotube insulation so that no electrical conduction path exists between the two.
- Wire conductors 168 and 170 extend from the proximal end of the catheter to each ring so that all electrode leads connected to a particular ring are interconnected electrically.
- alternating electrodes of a particular plurality are connected to two different rings.
- Each ring is separately connected to the power source and the polarities of the rings may therefore be made different to establish a bipolar approach within the plurality.
- One electrode may be a “+” polarity while the two adjacent electrodes may be a “ ⁇ ” polarity. In this case then, there would be a total of three rings for all electrodes.
- both pluralities would have two rings for its respective electrodes with alternating electrodes connected to different rings so that bipolar approaches within each plurality may be established. In this case, there would exist a total of four rings for the two pluralities of electrodes.
- An outer movable sheath 172 when slid in the distal direction to the point shown in FIG. 12 will cause the electrode leads to contract to the position shown.
- the sheath 172 acts as a deployment device in that it will move past the bend (not shown) in each of the electrode leads of the second plurality 122 permitting all electrode leads to expand outwardly as shown in FIG. 11 .
- the electrode leads are formed of stainless steel in this embodiment and with the thin insulation layer and the outward bend, have enough strength to automatically move outwardly through blood flow (in a venous application) and into apposition with the inner wall of the target tissue.
- the inner wall shrinks due to the application of heat by the electrodes, the inner wall will force the electrode leads toward their contracted position but the electrodes will automatically stay in apposition with the inner wall during the entire ligation process due to their outward bends and the material of which they are formed.
- the electrode 124 includes a temperature sensor 54 and an electrode of the second plurality also includes a temperature sensor 54 . Although not shown as such, they are mounted flush with the outer electrode surfaces and their wires protrude inwardly through the electrode and are held in place along the respective leads 152 and 154 .
- the microprocessor 52 receives the signals from both temperature sensors, averages those signals and determines the effective temperature at the treatment site based on that average signal. Methods of averaging temperature signals are well known to those skilled in the art and no further description is provided here.
- Electrodes and leads have been described as protruding from a distal orifice in the catheter, they may be expanded by other means and in other configurations. In another embodiment, the leads may be deployed by an inner pull wire, hydraulics, or magnetic fields.
- the benefits of tumescence would include locally anesthetizing the treatment area for a prolonged period of time and insulating most of the surrounding tissue and nerves from the damage of heat conducting from the treated vein.
- An additional benefit of the vasoconstriction induced by the Epinephrine would be that the constricted blood vessels would limit how fast the body absorbed the Lidocaine thus keeping the level of Lidocaine absorbed below the toxicity level.
- extended applications of energy have a greater possibility of increasing the temperature of the blood to an unacceptable level and may result in a significant amount of heat-induced coagulum forming on the electrode and in the vein which is not desirable.
- Using a tumescent anesthesia compression technique including the administration of vasoconstrictive drugs, would aid in preventing this problem by exsanguinating the vein.
Abstract
Description
- This application is a continuation of application Ser. No. 10/872,646 filed on Jun. 21, 2004, which is a continuation of application Ser. No. 09/899,885 (now U.S. Pat. No. 6,752,803) filed on Jul. 6, 2001, which is a continuation of Ser. No. 09/267,127 (now U.S. Pat. No. 6,258,084) filed on Mar. 10, 1999, which is a continuation-in-part of application Ser. No. 09/138,472 (now U.S. Pat. No. 6,179,832) filed on Aug. 21, 1998, which is a continuation-in-part of application Ser. No. 08/927,251 (now U.S. Pat. No. 6,200,312) filed on Sep. 11, 1997, the disclosures of which are all hereby incorporated by reference.
- The invention relates generally to a method and apparatus for applying energy to shrink a hollow anatomical structure, such as a fallopian tube or a vein, including but not limited to, superficial and perforator veins, hemorrhoids, and esophageal varices. In some particular aspects, the invention relates to a method for compressing an anatomical structure prior to the application of energy and apparatus including an electrode device having multiple leads for applying energy to the compressed structure to cause it to durably assume its compressed form.
- The human venous system of the lower limbs consists essentially of the superficial venous system and the deep venous system with perforating veins connecting the two systems. The superficial system includes the long or great saphenous vein and the short saphenous vein. The deep venous system includes the anterior and posterior tibial veins which unite to form the popliteal vein, which in turn becomes the femoral vein when joined by the short saphenous vein.
- The venous system contains numerous one-way valves for directing blood flow back to the heart such as those
valves 20 located in thevein 22 shown inFIG. 1 . The arrow leading out the top of the vein represents the antegrade flow of blood back to the heart. Venous valves are usually bicuspid valves, with eachcusp 24 forming a sack orreservoir 26 for blood which, under retrograde blood pressure, forces the free surfaces of the cusps together to prevent retrograde flow of the blood and allows only antegrade blood flow to the heart. Competent venous valves prevent retrograde flow as blood is pushed forward through the vein lumen and back to the heart. When anincompetent valve 28 is in the flow path, the valve is unable to close because the cusps do not form a proper seal and retrograde flow of the blood cannot be stopped. When a venous valve fails, increased strain and pressure occur within the lower venous sections and overlying tissues, sometimes leading to additional valvular failure. Incompetent valves may result from the stretching of dilated veins. As the valves fail, increased pressure is imposed on the lower veins and the lower valves of the vein, which in turn exacerbates the failure of these lower valves. A cross-sectional perspective view of a dilated vein with anincompetent valve 28 taken along lines 2-2 ofFIG. 1 is illustrated inFIG. 2 . Thevalve cusps 24 can experience some separation at the commissure due to the thinning and stretching of the vein wall at the cusps. Two venous conditions which often result from valve failure are varicose veins and more symptomatic chronic venous insufficiency. - The varicose vein condition includes dilation and tortuosity of the superficial veins of the lower limbs, resulting in unsightly discoloration, pain, swelling, and possibly ulceration. Varicose veins often involve incompetence of one or more venous valves, which allow reflux of blood within the superficial system. This can also worsen deep venous reflux and perforator reflux. Current treatments of vein insufficiency include surgical procedures such as vein stripping, ligation, and occasionally, vein-segment transplant.
- Chronic venous insufficiency involves an aggravated condition of varicose veins which may be caused by degenerative weakness in the vein valve segment, or by hydrodynamic forces acting on the tissues of the body, such as the legs, ankles, and feet. As the valves in the veins fail, the hydrostatic pressure increases on the next venous valves down, causing those veins to dilate. As this continues, more venous valves will eventually fail. As they fail, the effective height of the column of blood above the feet and ankles grows, and the weight and hydrostatic pressure exerted on the tissues of the ankle and foot increases. When the weight of that column reaches a critical point as a result of the valve failures, ulcerations of the ankle begin to form, which start deep and eventually come to the surface. These ulcerations do not heal easily because of poor venous circulation due to valvular incompetence in the deep venous system and other vein systems.
- Other related venous conditions include dilated hemorrhoids and esophageal varices. Pressure and dilation of the hemorrhoid venous plexus may cause internal hemorrhoids to dilate and/or prolapse and be forced through the anal opening. If a hemorrhoid remains prolapsed, considerable discomfort, including itching and bleeding, may result. The venous return from these prolapsed hemorrhoids becomes obstructed by the anal sphincters, which gives rise to a strangulated hemorrhoid. Thromboses result where the blood within the prolapsed vein becomes clotted. This extremely painful condition can cause edema and inflammation.
- Varicose veins called esophageal varices can form in the venous system with submucosa of the lower esophagus, and bleeding can occur from the dilated veins. Bleeding or hemorrhaging may result from esophageal varices, which can be difficult to stop and, if untreated, could develop into a life threatening condition. Such varices erode easily, and lead to a massive gastrointestinal hemorrhage.
- Ligation of a fallopian tube (tubal ligation) for sterilization or other purposes is typically performed by laparoscopy. A doctor severs the fallopian tube or tubes and ties the ends. External cauterization or clamps may also be used. General or regional anesthetic must be used. All of the above are performed from outside the fallopian tube.
- Hemorrhoids and esophageal varices may be alleviated by intra-luminal ligation. As used herein, “ligation” or “intra-luminal ligation” comprises the occlusion, collapse, or closure of a lumen or hollow anatomical structure by the application of energy from within the lumen or structure. As used herein, “ligation” or “intra-luminal ligation” includes electro-ligation. In the case of fallopian tube ligation, it would be desirable to perform the ligation from within the fallopian tube itself (intra-fallopian tube) to avoid the trauma associated with external methods.
- Ligation involves the cauterization or coagulation of a lumen using energy, such as that applied through an electrode device. An electrode device is introduced into the lumen and positioned so that it contacts the lumen wall. Once properly positioned, RF energy is applied to the wall by the electrode device thereby causing the wall to shrink in cross-sectional diameter. In the case of a vein, a reduction in cross-sectional diameter of the vein, as for example from 5 mm (0.2 in) to 1 mm (0.04 in), significantly reduces the flow of blood through a lumen and results in an effective occlusion. Although not required for effective occlusion or ligation, the vein wall may completely collapse thereby resulting in a full-lumen obstruction that blocks the flow of blood through the vein. Likewise, a fallopian tube may collapse sufficiently to effect a sterilization of the patient.
- One apparatus for performing ligation includes a tubular shaft having an electrode device attached at the distal tip. Running through the shaft, from the distal end to the proximal end, are electrical leads. At the proximal end of the shaft, the leads terminate at an electrical connector, while at the distal end of the shaft the leads are connected to the electrode device. The electrical connector provides the interface between the leads and a power source, typically an RF generator. The RF generator operates under the guidance of a control device, usually a microprocessor.
- The ligation apparatus may be operated in either a monopolar or bipolar configuration. In the monopolar configuration, the electrode device consists of an electrode that is either positively or negatively charged. A return path for the current passing through the electrode is provided externally from the body, as for example by placing the patient in physical contact with a large low-impedance pad. The current flows between the ligation device and low impedance pad through the patient. In a bipolar configuration, the electrode device consists of a pair of electrodes having different potentials (such as a pair of oppositely-charged electrodes) of approximately equal size, separated from each other, such as by a dielectric material or by a spatial relationship. Accordingly, in the bipolar mode, the return path for current is provided by an electrode or electrodes of the electrode device itself. The current flows from one electrode, through the tissue, and returns by way of another electrode.
- To protect against tissue damage, i.e., charring, due to cauterization caused by overheating, a temperature sensing device is typically attached to the electrode device, although it may be located elsewhere. The temperature sensing device may be a thermocouple that monitors the temperature of the venous tissue. The thermocouple interfaces with the RF generator and the controller through the shaft and provides electrical signals to the controller which monitors the temperature and adjusts the energy applied to the tissue through the electrode device accordingly.
- The overall effectiveness of a ligation apparatus is largely dependent on the electrode device contained within the apparatus. Monopolar and bipolar electrode devices that comprise solid devices having a fixed shape and size can limit the effectiveness of the ligating apparatus for several reasons. Firstly, a fixed-size electrode device typically contacts the vein wall at only one point or a limited arc on the circumference or inner diameter of the vein wall. As a result, the application of RF energy is highly concentrated within the contacting venous tissue, while the flow of RF current through the remainder of the venous tissue is disproportionately weak. Accordingly, the regions of the vein wall near the area of contact collapse at a faster rate than other regions of the vein wall, resulting in non-uniform shrinkage of the vein lumen. Furthermore, the overall strength of the occlusion may be inadequate and the lumen may eventually reopen. To avoid an inadequate occlusion, RF energy must be applied for an extended period of time so that the current flows through the tissue, including through the tissue not in contact with the electrode, generating thermal energy and causing the tissue to shrink sufficiently. Extended applications of energy have a greater possibility of increasing the temperature of the blood to an unacceptable level and may result in a significant amount of heat-induced coagulum forming on the electrode and in the vein which is not desirable. Furthermore, it is possible for the undesirable coagulum to form when utilizing an expandable electrode as well. This problem can be prevented by exsanguination of the vein prior to the treatment, as well as through the use of temperature-regulated power delivery. As used herein, “exsanguination” comprises the removal of all or some significant portion of blood in a particular area.
- Secondly, the effectiveness of a ligating apparatus having a fixed-size electrode device is limited to certain sized veins. An attempt to ligate a vein having a diameter that is substantially greater than the fixed-size electrode device can result in not only non-uniform heating of the vein wall as just described, but also insufficient shrinkage of the vein diameter. The greater the diameter of the vein relative to the diameter of the electrode device, the weaker the energy applied to the vein wall at points distant from the point of electrode contact. Also, larger diameter veins must shrink a larger percentage for effective occlusion to occur. Accordingly, the vein wall is likely to not completely collapse prior to the venous tissue becoming over-cauterized at the point of electrode contact. While coagulation as such may initially occlude the vein, such occlusion may only be temporary in that the coagulated blood may eventually dissolve recanalizing the vein. One solution for this inadequacy is an apparatus having interchangeable electrode devices with various diameters. Another solution is to have a set of catheters having different sizes so that one with the correct size for the diameter of the target vein will be at hand when needed. Such solutions, however, are both economically inefficient and can be tedious to use. It is desirable to use a single catheter device that is usable with a large range of sizes of lumina.
- A technique of reducing the diameter of the lumen of a vein at least close to the final desired diameter before applying energy to the vein has been found to aid in the efficiency of these types of procedures. The pre-reduction in vein diameter assists in pre-shaping the vein to be molded into a ligated state. The compression also exsanguinates the vein and forces blood away from the treatment site, thus preventing coagulation. One valuable technique employed is that of compressing the vein contained within a limb by applying external hydraulic pressure, via a pressure tourniquet, to the limb. Unfortunately there are some areas of the body to which a pressure tourniquet cannot be applied, such as the sapheno-femoral junction, which is above the thigh proximate the groin area. Furthermore, there are sites where a pressure tourniquet may be ineffective such as: the popliteal junction and other areas around the knee; and the ankle area (typically the posterior arch vein and some of the lower cockett perforators).
- There exists a technique referred to as tumescent anesthesia that has been used in connection with liposuction procedures. The word “tumescent” means swollen or firm. This technique is accomplished by subcutaneously delivering into target fatty tissue a large volume of saline solution containing diluted Lidocaine and Epinephrine (adrenaline), a vasoconstrictive drug. The injected area then becomes locally anesthetized, and the adrenaline temporarily constricts the capillaries and other blood vessels. The tumescence-inducing fluid, or “tumescent fluid,” is injected under pressure which causes the target fatty tissue to become swollen and firm. The tumescent fluid is typically pumped into the pocket of fat in order to numb the area, loosen the fat, and constrict the blood vessels to minimize bleeding or bruising in a liposuction procedure. The anesthetic and other agents in the tumescent solution should be allowed sufficient time to diffuse and take full effect throughout the target tissue. After surgery, patients may leave without assistance, and often return to their regular routine within several days. With the tumescent technique, postoperative discomfort is significantly reduced. The local anesthesia often remains in the treated tissue for 16 hours after surgery. Employing a technique of utilizing tumescent anesthesia in conjunction with ligation or radial lumen shrinkage less than ligation may provide benefits.
- Although described above in terms of a vein, the concepts are generally applicable to other hollow anatomical structures in the body as well. The above description has been generally confined to veins in consideration of avoiding unnecessary repetition.
- Hence those skilled in the art have recognized a need for an improved method and apparatus that can be used on areas of the body to shrink and ligate hollow anatomical structures. A need has also been recognized for an improved method and apparatus to pre-compress and exsanguinate a hollow anatomical structure while providing anesthetic and insulation benefits during the radial shrinkage of the hollow anatomical structure. The invention fulfills these needs and others.
- The present invention is directed to a method and apparatus for applying energy to a hollow anatomical structure such as a vein, to shrink the structure. In a more detailed aspect, the invention is directed to pre-compressing and exsanguinating a hollow anatomical structure while providing anesthetic and insulation benefits during a procedure of shrinking the hollow anatomical structure.
- In another aspect of the present invention, a method comprises providing fluid to tissue surrounding a hollow anatomical structure to induce tumescence of the tissue and consequent compression of the hollow anatomical structure during a procedure of applying energy to the hollow anatomical structure from within the structure. In a more detailed aspect, the method comprises introducing into the hollow anatomical structure a catheter having a working end and at least one electrode at the working end; placing the electrode into contact with the inner wall of the pre-compressed hollow anatomical structure and applying energy to the hollow anatomical structure at the treatment site via the electrode until the hollow anatomical structure durably assumes dimensions less than or equal to the pre-compressed dimensions caused by the injection of the solution into the tissue.
- In another aspect in accordance with the invention, tumescent fluid is injected in the tissue surrounding the hollow anatomical structure along a selected length of the hollow anatomical structure. The electrode is then moved along a site within the selected length while continuously applying energy to result in a lengthy occlusion. In another approach, after an initial application of energy to one site internal to the hollow anatomical structure within the selected length, the electrode is moved down a given length of the hollow anatomical structure and energy is applied at that adjacent site. For the site where energy is applied, the hollow anatomical structure durably assumes dimensions less than or equal to the pre-compressed dimensions caused by the injection of the solution into the tissue.
- In a more detailed aspect, tumescent anesthesia fluid is injected or otherwise provided to tissue contiguous with a vein to compress the vein to about a desired final diameter. A catheter having an energy application device, such as expandable electrodes, is introduced internal to the vein at a site within the compressed portion of the vein and energy is applied to the internal vein wall by the application device. Sufficient energy is applied to cause the vein to durably assume the compressed diameter such that when the effects of the tumescent anesthesia fluid are dissipated, the vein retains the compressed diameter.
- Alternate means to prevent coagulum formation include fluid displacement of blood at the treatment site, or exsanguination by inducing self-constriction of the vessel. In the latter, self-constriction includes, but is not limited to, intraluminal delivery of a vasoconstrictive drug. Self-constriction also aids in pre-shaping the vein for ligation, as discussed previously. If the fluid delivered to the site is a sclerosant, the ligation effects would be further enhanced.
- In further aspects, energy is applied to effectively occlude the treatment site. Further, the energy application device is moved along the treatment site while performing the step of applying energy so as to result in a lengthy occlusion of the treatment site. The treatment site may collapse around the energy application device as it is being moved. In yet further detail, fluid is delivered from within the hollow structure to the treatment site. This fluid may be used to exsanguinate the treatment site. Such fluid may be from the following group: saline; a vasoconstrictive agent; a sclerosing agent; a high impedance fluid; and heparin. In another aspect, temperatures are sensed at two separate locations on the energy application device, and the temperature signals are averaged to determine the temperature at the site. In further detailed aspects, electrical energy is applied to the inner wall of the treatment site with an electrode, the electrode being in apposition with the inner wall. With the electrode being in apposition with the inner wall, the method further comprises the steps of applying electrical energy with the electrode to effectively occlude the treatment site at the electrode, and moving the electrode along the treatment site while maintaining the electrode in apposition with the vein wall while performing the step of applying energy to effectively occlude the treatment site so as to result in a lengthy effective occlusion of the treatment site. Sufficient energy is applied to collapse the hollow anatomical structure around the energy application device as it is being moved along the treatment site to result in a lengthy effective occlusion of the treatment site.
- In yet a further aspect, apposition of the energy application device with the inner wall of the hollow anatomical structure is determined by monitoring the impedance experienced by the energy application device.
- These and other aspects and advantages of the present invention will become apparent from the following more detailed description, when taken in conjunction with the accompanying drawings which illustrate, by way of example, embodiments of the invention.
-
FIG. 1 shows a cross-sectional view of a vein having competent valves and having a dilated section with incompetent venous valves in a lower limb which are to be treated in accordance with the present invention; -
FIG. 2 shows a representative view of a venous section with an incompetent valve fromFIG. 1 taken along line 2-2 which is to be treated in accordance with the present invention; -
FIG. 3 is a cross-sectional view of the vein ofFIG. 1 after the vein has been compressed, although not to full occlusion, by the injection of a tumescent anesthesia fluid in tissue surrounding the vein showing a catheter including an expandable electrode device prior to the application of energy to the vein; -
FIG. 4 is a diagram of an energy application system that may be used in conjunction with the method of the present invention, depicting a partial cutaway view of the first embodiment of the catheter showing both the working end and the connecting end with an RF generator and a microprocessor connected at the connection end; -
FIG. 5 is a cross-sectional view of the working end of an embodiment of a catheter in accordance with the invention depicting the electrodes in a fully retracted position; -
FIG. 5 a is an end view of the working end of the embodiment of the catheter taken along line 5 a-5 a ofFIG. 5 ; -
FIG. 6 is a cross-sectional view of the working end of the embodiment of the catheter ofFIGS. 5 and 5 a depicting the electrodes in a fully expanded position; -
FIG. 6 a is an end view of the working end of the embodiment of the catheter taken alongline 6 a-6 a ofFIG. 6 ; -
FIG. 7 is a cross-sectional view of a vein after the vein has been compressed, although not to full occlusion, by tumescent anesthesia fluid, the vein containing the catheter ofFIG. 5 with the electrodes in apposition with the vein; -
FIG. 8 is a cross-sectional view of the compressed vein containing the catheter ofFIG. 5 where the vein is being ligated by the application of energy from the electrodes; -
FIG. 9 is a partial cross-sectional view of the vein wall ofFIG. 8 showing a lengthy effective occlusion made by moving the electrodes along the treatment site of the vein while maintaining the electrodes in apposition and continuing to apply energy to the vein wall. -
FIG. 10 is a side view of an embodiment of an electrode catheter having two pluralities of longitudinally-separated expandable electrodes in a retracted condition; -
FIG. 11 is a side view of the embodiment of the electrode catheter ofFIG. 10 with both pluralities of the electrodes in expanded configurations; and -
FIG. 12 is a partial cross-sectional view of the embodiment of an electrode catheter ofFIGS. 10 and 11 . - As shown in the exemplary drawings, the invention is directed toward the intravenous treatment of veins using a catheter to deliver at least one electrode to a venous treatment site. As used herein, like reference numerals will designate similar elements in the various embodiments of the present invention to be discussed. In addition, unless otherwise noted, the term “working end” will refer to the direction toward the treatment site in the patient, and the term “connecting end” will refer to the direction away from the treatment site in the patient. The invention will be described in relation to the treatment of the venous system of the lower limbs. It is to be understood, however, that the invention is not limited thereto and may be employed intraluminally to treat veins in other areas of the body such as hemorrhoids, esophageal varices, and venous-drainage-impotence of the penis. Furthermore, although the invention will be described as using RF energy from the electrode, it is to be understood that other forms of energy such as microwaves, ultrasound, direct current, circulating heated fluid, radiant light, and lasers can be used, and that the thermal energy generated from a resistive coil or Curie point element may be used as well.
- Turning to
FIG. 3 , one preferred method of the present invention can be performed using thecatheter 30 to deliver an expandable electrode device 32 (partially shown) to a venous treatment site in order to ligate the vein. Instead of compressing the tissue surrounding the treatment site via a pressure tourniquet, a tumescent anesthesia technique can be used to inject a dilute anesthetic and vasoconstrictive solution into the tissue surrounding the vein to be treated. The tumescent solution preferably includes mostly saline solution, with a local anesthetic such as Lidocaine, and a vasoconstrictive drug such as Epinephrine. The tumescent solution causes the surroundingtissue 34 to become swollen which compresses thevein 22, as indicated by the arrows, dose to occlusion (in this case) or to occlusion. Sufficient tumescent solution should be delivered into the tissue surrounding the vein to compress and exsanguinate the vein. Before injecting the tumescent solution, thecatheter 30 is placed within the vein at the treatment site, with the expandable electrode device retracted. - The solution is typically infused with a peristaltic pump. However, 60 cc or 100
cc syringes 35 can be used. Another alternative is an IV bag with a pressure cuff. Large volumes are typically delivered into the perivenal area via a large cannula. Sites are typically located 10 cm apart down the leg. Usually there are four or five delivery sites. The external result is a leg that appears inflated. The internal result is compressed veins plus an anesthetized leg. The expandable electrode device is then expanded into apposition with the venous tissue after compression of the vein. Energy such as high frequency RF energy is applied from the expandable electrode device to the venous tissue until the vein durably assumes dimensions less than or equal to the compressed dimensions caused by the injection of the tumescent solution into the tissue. - After completing the procedure for a selected venous section or treatment site, the electrode may be retracted and the catheter moved to another venous section where the ligation process is repeated. Ultrasound guidance can be used to monitor the progress of the procedure.
- One preferred embodiment of the catheter for delivering an expandable energy application device or
expandable electrode device 56 to the venous treatment site is illustrated inFIG. 4 . Thecatheter 30 includes an expandableenergy application device 56 which in this embodiment, comprises an array ofelectrodes 58, anouter sheath 36 having adistal orifice 38 at its workingend 40. Theconnector end 42 of the outer sheath is attached to ahandle 44 that includeselectrical connector 46. The handle additionally includes aguide wire port 48. Theconnector 46 is for interfacing with a power source, typically anRF generator 50, and amicroprocessor controller 52. The power source and microprocessor controller are usually contained in one unit. The microprocessor controller controls the RF generator in response to external commands and data from atemperature sensor 54, such as a thermocouple, or temperature sensors that may be positioned at an intraluminal venous treatment site. - The
catheter 30 includes theexpandable electrode device 56 that moves in and out of the outer sheath by way of thedistal orifice 38 in this embodiment, although in other embodiments thedevice 56 may expand from and contract into thecatheter 30 at other locations. Theexpandable electrode device 56 includes a plurality ofelectrodes 58 which can be expanded by moving theouter sheath 36 relative to the electrodes. AlthoughFIG. 4 illustrates a plurality ofelectrodes 58 surrounding a single central electrode, different electrode configurations may be used. - Contained within the
outer sheath 36 is aninner sheath 60 or inner member as shown in the cutaway portion ofFIG. 4 . Afluid port 62 communicates with the interior of the outer sheath. Thecatheter 30 can be periodically flushed out with saline through the fluid port. The flushing fluid can travel between the outer sheath and the inner sheath. The fluid port also allows for the delivery of drug therapies. Flushing out the catheter prevents the buildup of biological fluid, such as blood, within the catheter. The treatment area or site of the vein can be flushed with a fluid such as saline, or a high impedance dielectric fluid, in order to evacuate blood from the treatment area of the vein so as to prevent the formation of coagulum or thrombosis. The use of a high impedance dielectric fluid can minimize unintended heating effects away from the treatment area. The dielectric fluid directs the current of RF energy toward the vein wall. In addition, a vasoconstrictive agent may be applied to shrink the vein, heparin may be applied for coagulation avoidance, and a sclerosing agent may be applied to assist in ligation. These drugs or agents may be applied before, during, or after the catheter is used to heat the vein wall. - In one preferred embodiment, the
catheter 30 includes a lumen which begins at the distal tip 55, proximate the workingend 40, and runs substantially along the axis of the inner member before terminating at theguide wire port 48 of thehandle 44. A guide wire can be introduced through the lumen of the catheter for use in guiding the catheter to the desired treatment site. Where the catheter is sized to treat smaller veins, the outer diameter of the catheter may not allow for a fluid flush between the outer sheath and theinner sheath 60. However, a fluid flush can be introduced through theguide wire port 48 in such an embodiment. - Turning again to
FIG. 4 , anactuator 76 controls the extension of theelectrode device 56 through thedistal orifice 38. The actuator may take the form of a switch,lever 78, threaded control knob, or other suitable mechanism, and is preferably one that can provide fine control over the movement of theouter sheath 36 or theinner sheath 60, as the case may be. In one embodiment of the invention, the actuator interfaces with the outer sheath to move it back and forth relative to the inner sheath. In another embodiment the actuator interfaces with the inner sheath to move it back and forth relative to the outer sheath. The relative position between the outer sheath and inner sheath is thus controlled, but other control approaches may be used. - A preferred embodiment of a
catheter 90 is illustrated inFIG. 5 . Aninner member 92 or sheath is contained within theouter sheath 94. The inner sheath is preferably constructed from a flexible polymer such as polymide, polyethylene, or nylon, and can travel the entire length of the catheter. The majority of the catheter should be flexible so as to navigate the tortuous paths of the venous system. A hypotube having a flareddistal end 98 and a circular cross-sectional shape is attached over the distal end of theinner sheath 92. Thehypotube 96 is preferably no more than about two to three centimeters in length. The hypotube acts as part of a conductivesecondary lead 100. An uninsulatedconductive electrode sphere 102 is slipped over the hypotube. The flared distal end of the hypotube prevents the electrode sphere from moving beyond the distal end of the hypotube. The sphere is permanently affixed to the hypotube, such as by soldering the sphere both front and back on the hypotube. The majority of the surface of the electrode sphere remains uninsulated. The remainder of the hypotube is preferably insulated so that the sphere-shaped distal end can act as the electrode. For example, the hypotube can be covered with an insulating material such as a coating of parylene. The interior lumen of the hypotube is lined by theinner sheath 92 which is attached to the flared distal end of the hypotube by adhesive such as epoxy. - Surrounding the
secondary lead 100 are a plurality ofprimary leads 104 that preferably have a flat rectangular strip shape and can act as arms. In one configuration, the strip shape is a width from 0.76 mm (0.03 in) to 1.00 mm (0.04 in) and a thickness of approximately 0.13 mm (0.005 in.). As illustrated inFIG. 6 , the plurality ofprimary leads 104 is preferably connected to common conductive rings 106. This configuration maintains the position of the plurality of primary leads, while reducing the number of internal electrical connections. The conductive rings 106 are attached to theinner sheath 92. The position of the rings and the primary leads relative to theouter sheath 94 follows that of the inner sheath. As earlier described, thehypotube 96 of the secondary lead is also attached to the inner sheath. Two separate conductive rings can be used so that the polarity of different primary leads can be controlled separately. For example, adjacent primary leads can be connected to one of the two separate conductive rings so that the adjacent leads can be switched to have either opposite polarities or the same polarity. The rings are preferably spaced closely together, but remain electrically isolated from each other along the inner sheath. Both the rings and the hypotube are coupled with the inner sheath, and the primary leads that are connected to the rings move together with the secondary lead while remaining electrically isolated from the secondary lead. Epoxy or another suitable adhesive can be used to attach the rings to the inner sheath. The primary leads from the respective rings alternate with each other along the circumference of the inner sheath. The insulation along the underside of the leads prevents an electrical short between the rings.FIG. 6 a illustrates an end view of the working end ofcatheter 90 taken alongline 6 a-6 a ofFIG. 6 . - The conductive rings 106 and the primary leads 104 are attached together to act as cantilevers where the ring forms the base and the rectangular primary leads operate as the cantilever arms. The primary leads are formed to have an arc or bend such that the primary leads act as arms that tend to spring outwardly away from the
catheter 90 and toward the surrounding venous tissue. Insulation along the underside of the primary leads and the conductive rings prevents unintended electrical coupling therebetween. Alternately, the primary leads are formed straight and connected to the conductive rings at an angle such that the primary leads tend to expand or spring radially outward from the conductive rings. The angle at which the primary leads are attached to the conductive rings should be sufficient to force the primary distal ends and theirelectrodes 108 through blood and into apposition with thevein wall 80 but not enough to preclude vein shrinkage. In particular, the primary leads 104 are formed with enough strength, and are mounted or bent such that they expand outwardly into apposition with the inner wall of the vein. However, the force they develop in an outward direction is not strong enough to prevent radial shrinkage of the vein. As the vein shrinks, due to the heating caused by the energy delivered by theelectrodes 108, the shrinking vein causes a contraction of the primary electrodes. Due to the outward force constantly exerted by the primary leads 104, theelectrodes 108 remain in constant apposition with the vein wall as it shrinks. - Other properties of the primary leads, such as lead shape and insulation thickness, affect the push force of the lead against the vein wall and the degree of arc or bend must be adjusted to compensate for these factors. The rectangular cross section of the primary leads can provide increased stability in the lateral direction while allowing the necessary bending in the radial direction. The primary leads are less likely to bend sideways when expanded outward due to the increased size of the rectangular lead in that sideways direction, and a uniform spacing between primary leads is more assured. Uniform spacing between the primary leads and the distal ends promotes uniform heating around the vein by the
electrodes 108. - The distal ends of the primary leads 104 are uninsulated to act as the
electrodes 108 having a rounded shape. In the embodiment shown, the shape is convex which may take the form of a spoon or hemispherical shape. The primary leads can be stamped to produce an integral shaped electrode at the distal end of the primary leads. The uninsulated outer portion of the distal end of theelectrodes 108 which are to come into apposition with the wall of the vein is preferably rounded and convex. The flattened or non-convex inner portion of the distal end is insulated to minimize any unintended thermal effect, such as on the surrounding blood in a vein. The distal ends of theelectrodes 108 are configured such that when the distal ends are forced toward theinner sheath 92, as shown inFIG. 5 a, the distal ends combine to form a substantially spherical shape with a profile smaller than thespherical electrode 102 at the secondary distal end. - In one preferred embodiment as shown in
FIG. 6 , theelectrodes 108 comprise a convex, square center section with semi-circular ends. It has been found that this “race track” configuration maximizes surface area of contact for theelectrodes 108 shown. - The
outer sheath 94 can slide over and surround the primary andsecondary leads orifice 110 which is dimensioned to have approximately the same size as thespherical electrode 102 at the secondary distal end. A close or snug fit between thespherical electrode 102 and theorifice 110 of the outer sheath is achieved. This configuration provides an atraumatic tip for thecatheter 90. Thespherical electrode 102 is preferably slightly larger than theorifice 110. The inner diameter of the outer sheath is approximately the same as the diameter of the reduced profile of the combined primarydistal end electrodes 108. - A fluid port (not shown) can communicate with the interior of the
outer sheath 94 so that fluid can be flushed between the outer sheath andinner sheath 92 as described above. Alternately, a fluid port can communicate with acentral lumen 112 in the hypotube which can also accept a guide wire for use in guiding the catheter to the desired treatment site. It is to be understood that another lumen can be formed in the catheter to deliver fluid to the treatment site. The delivered fluid displaces or exsanguinates blood from the vein so as to avoid heating and coagulation of blood. The delivery of a dielectric fluid increases the surrounding impedance so that RF energy is directed into the tissue of the vein wall. An alternate fluid could be a sclerosing agent which could serve to displace blood or to further enhance occlusion of the vein when applied before, during, or after energy delivery. The fluid can also include an anticoagulant such as heparin which can chemically discourage the coagulation of blood at the treatment site. Thecatheter 90 can be periodically flushed with saline which can prevent the buildup of biological fluid, such as blood, within the catheter. The saline can be flushed through thecentral lumen 112 or between the inner and outer sheaths. If a central lumen is not desired, the lumen of the hypotube can be filled with solder. - The
electrode device 114 can operate in either a bipolar or a monopolar configuration. When adjacent primary leads have opposite polarity, a bipolar electrode operation is available. When the primary leads are commonly charged a monopolar electrode operation is available in combination with a large return electrode pad placed in contact with the patient. When theprimary electrodes 108 are commonly charged or have a first potential, and asecondary electrode 102 has an opposite polarity or different potential, a bipolar electrode operation is available. More or fewer leads may be used. The number of leads can be dependent on the size or diameter of the vein to be treated, as described above. - Although not shown, it is to be understood that the
catheter 90 can include one or more temperature sensors, such as thermocouples, mounted in place on anelectrode 108 so that the sensor is substantially flush with the exposed surface of theelectrode 108. (The sensor is shown in a raised position in the drawings for clarity of illustration only). The temperature sensor senses the temperature of the portion of the vein that is in apposition with the exposedelectrode 108 surface. The sensor provides an indication of when shrinkage occurs (70 degrees C. or higher). Application of RF energy from theelectrodes 108 is halted or reduced when the monitored temperature reaches or exceeds the specific temperature that was selected by the operator, such as the temperature at which venous tissue begins to cauterize. Other techniques such as impedance monitoring and ultrasonic pulse echoing can be utilized in an automated system which shuts down or regulates the application of RF energy from the electrodes to the venous section when sufficient shrinkage of thevein 22 is detected. This also helps to forestall overheating of the vein. - Referring now to
FIGS. 7 and 8 , in the operation of this embodiment of acatheter 90, the catheter is inserted into avein 22. Fluoroscopy, ultrasound, an angioscope imaging technique, or another technique may be used to direct and confirm the specific placement of the catheter in the vein. Impedance measurements can also be used to determine proper positioning of the catheter, particularly at the ostium of a vessel such as at the sapheno-femoral junction. The impedance will be low when the electrodes are in the blood stream. The catheter can then be moved until a high impedance value is obtained, indicating electrode contact with the vein wall. Thevein wall 80 has been compressed by the introduction of tumescent anesthesia into the tissue surrounding the vein as indicated by the arrows. The arrows in the figures indicate the compression of the tissue. Unless stated otherwise, all drawing figures having arrows indicating tissue compression are not drawn to scale for purposes of clarity of illustration and are meant to be representations of the vein in a nearly fully occluded state. - The reduction in the
vein 22 diameter caused by the tumescence of the tissue in contact with the treatment site assists in pre-shaping the vein to be molded to a ligated state. The compression also exsanguinates the vein and forces blood away from the treatment site, thus preventing coagulation. - The actuator 76 (
FIG. 4 ) is then operated to retract theouter sheath 94 to expose leads the 100 and 104. As the outer sheath no longer restrains the leads, the primary leads 104 move outward relative to the axis defined by the outer sheath, while thesecondary lead 100 remains substantially linear along the axis defined by the outer sheath. The primary leads continue to move outward until theirelectrodes 108 are placed in apposition with thevein wall 80 and the outward movement of the primary leads is impeded. Theprimary electrodes 108 contact the vein wall along a generally circumferential area or band of the vein wall. This outward movement of the primary leads occurs in a substantially symmetrical fashion so that theprimary electrodes 108 are substantially evenly spaced. Alternately, the electrodes 86 can be spaced apart in a staggered fashion such that they do not lie in the same plane. For example, the adjacent electrodes 86 can extend different lengths from the catheter so that a smaller cross-sectional profile is achieved when the electrodes 86 are collapsed toward one another. - When the
electrodes RF generator 50 is activated to provide suitable RF energy. One suitable frequency is 510 kHz. One criterion used in selecting the frequency of the energy to be applied is the control desired over the spread, including the depth, of the thermal effect in the venous tissue. Another criterion is compatibility with filter circuits for eliminating RF noise from thermocouple signals. In a bipolar operation, theprimary electrodes 108 are charged with one polarity opposite that of thesecondary electrode 102. The coupling between oppositely charged primary and secondary electrodes produces RF fields therebetween, and form a symmetrical RF field pattern along a circumferential band of thevein wall 80 to achieve a uniform temperature distribution along the vein wall being treated. - The RF energy produces a thermal effect which causes the venous tissue to shrink, reducing the diameter of the
vein 22. The thermal effect produces structural transfiguration of the collagen fibrils in the vein. The collagen fibrils shorten and thicken in cross-section in response to the heat from the thermal effect. As shown inFIG. 8 , the energy causes thevein wall 88 to collapse until further collapse is impeded by theprimary lead electrodes 108. The primary lead electrodes are pressed closer together by the shrinking vein wall and assume a reduced profile shape which is sufficiently small so that the vein is effectively ligated. - The
catheter 90 is pulled back while continuing energy delivery as shown inFIG. 9 . Ligation as the catheter is being retracted produces alengthy occlusion 89 which is stronger and less susceptible to recanalization than an acute point occlusion. - In a monopolar operation, the secondary-
lead electrode 102 remains neutral, while theprimary electrodes 108 are commonly charged and act in conjunction with an independent electrical device, such as a large low-impedance return pad (not shown) placed in external contact with the body, to form RF fields substantially evenly spaced around the circumference of the vein. The thermal effect produced by those RF fields along the axial length of thevein wall 80 causes the vein wall to collapse around the primary lead electrodes. The electrode device is retracted as described in the bipolar operation. - In either bipolar or monopolar operation the application of RF energy is substantially symmetrically distributed through the vein wall, as previously described. The electrodes should be spaced no more than 4 or 5 millimeters apart along the circumference of the
vein wall 80, which defines the target vein diameter for a designed electrode catheter. Where the electrodes are substantially evenly spaced in a substantially symmetrical arrangement, and the spacing between the electrodes is maintained, a symmetrical distribution of RF energy increases the predictability and uniformity of the shrinkage and the strength of the occlusion. - Although not shown, in another embodiment, the primary leads may be mounted or otherwise configured such that they expand outwardly in an asymmetrical fashion. One purpose for an asymmetrical electrode arrangement is to only shrink a portion of the vein wall to achieve occlusion. Such may be desired in the case of preferentially shrinking a tributary branch or aneurysm on one side of the vein.
- After completing the procedure for a selected venous section or treatment site, the
actuator 76 causes the primary leads 104 to return to the interior of theouter sheath 94. Once the primary leads are within the outer sheath, thecatheter 90 may be moved to another venous section where the ligation process is repeated. - As illustrated in
FIGS. 10 and 11 , another embodiment of anexpandable electrode catheter 118 includes two sets of expandable electrode leads 120 and 122, although additional sets of electrode leads may be possible. Theelectrodes 124 of this embodiment are similar to the electrodes of the embodiment illustrated inFIG. 6 having electrodes with a rounded, convex, spoon-shaped contact area. Other shapes for the electrode may be used, such as ellipses, rounded, ovals, race tracks, and others. Although only one electrode is indicated by numeral 124 inFIGS. 10 and 11 , this is for purposes of clarity in the drawings only. All electrodes are meant to be indicated bynumeral 124. While each set of electrode leads may include as few as two electrode leads, the illustrated embodiment includes six electrode leads per set, although more than six electrode leads may be used as well. - In the embodiment shown in
FIGS. 10 and 11 , the sets of electrode leads 120 and 122 are longitudinally separated from each other. Thus, the electrodes within each set of electrode leads are separated from one another radially and each of those electrodes is also separated from every electrode in the other set longitudinally, due to the longitudinal separation. There therefore exists radial separation and longitudinal separation of electrodes at the workingend 126 of thecatheter 118 in the arrangement shown inFIGS. 10 and 11 . - With the configuration of electrode leads presented in
FIGS. 10 and 11 , greater flexibility exists in establishing current flows through the tissue of a patient. As in previous embodiments, the electrodes expand outwardly into contact with patient tissue. Where all the electrodes of a first set of electrode leads have the same polarity, there may be an odd number of electrodes in the set, or an even number. All electrodes in the set may be connected to a common connection point, such as the conductingring 106 shown inFIG. 6 . A single conductor from the connecting end of the catheter may power all electrodes of the set by a single connection to that conducting ring. All electrodes of a second set of electrode leads may also be commonly connected at a respective conducting ring but to a different electrical potential than the first set. Because two different electrical potentials exist at the working end of the catheter, energy will flow through the patient tissue between those sets of electrode leads and a bipolar arrangement will exist. Thus, a length of patient tissue, at least as long as the distance between the first and second sets of electrode leads, will receive the energy. - A monopolar arrangement may also be established if desired by setting all electrodes of all electrode leads to the same electrical potential and establishing a different electrical potential outside the patient, such as at a “backplate” in contact with the skin of the patient at a selected location. Energy from the working
end 126 of the catheter will then flow through the patient to the return provided by the backplate. - In another arrangement in polarizing or controlling the electrical potential at the electrodes, the electrodes in the first set of electrode leads may be individually controlled so that there are electrode pairs of differing potentials in the set of leads. This would establish a bipolar approach within the first set of leads itself. If the electrodes of the second set of leads are likewise connected for different potentials among themselves, they too would provide a bipolar approach in their own set and currents would flow through patient tissue between the electrodes in each set of leads. If the electrodes having a first polarity in the first set are aligned with the electrodes having a different polarity in the second set of leads, energy would not only flow between the bipolar electrodes within the set but would also flow to the electrodes in the other set resulting in two bipolar arrangements at the single working end of the catheter. Patient tissue of a length at least as great as the distance between the first and second sets of electrode leads will receive energy, as well as, patient tissue between electrodes within each set of leads itself.
- A further arrangement coupled with the bipolar approach just described would be to also use a backplate at a different electrical potential to provide further control over the energy flow through the patient's tissue. In this case, energy would flow between the electrodes within each set of leads, between electrodes in different sets of leads, and between electrodes and the backplate.
- In yet a further arrangement, each of the electrodes may be individually connected to a power source (50,
FIG. 4 ) and the electrical potential at each electrode can be individually controlled. This arrangement may yield even more precise control over the current densities through patient tissue. As an example, where less current flow is desired between certain electrodes of a set of leads but more current flow is desired between those electrodes and electrodes of a second set of leads, the potential between the electrodes of the same set may be reduced but the potential between those electrodes and the electrodes of the second set of leads may be increased resulting in the desired current flow densities. In the case where a backplate is also used, the electrodes may be controlled so that energy flows between such electrodes and the backplate. Because each electrode is individually controlled, the level of energy it imparts to the tissue at its location is controllable. - One factor that could affect the number of electrodes per set of electrode leads is the diameter of the vein being treated. The design of the contact pad for the electrode leads could also affect the desired number of electrodes for a given procedure.
- In this embodiment, the electrode leads 120, 122 are formed to expand outwardly into apposition with the target tissue, yet as the target tissue shrinks, the electrodes maintain contact with that tissue and are moved inwardly by that tissue. Because of this arrangement, the leads compensate for variations in the diameter of the vein. They are therefore capable of maintaining apposition with the tissue whether or not compression of the vein or anatomical structure exists, such as by use of a pressure cuff or tourniquet or tumescence of the surrounding tissue.
- The
tip 128 of theelectrode catheter 118 should have a hemispherical or another atraumatic shape. Thetip 128 may be electrically neutral, and may be fabricated from a polymer or it may be fabricated of stainless steel. Because thetip 128 has a rounded shape and is located at the distal extreme of the catheter, it may perform a guiding function when introducing the catheter to the patient. - The double set of expandable electrodes can be used to ligate veins or other hollow anatomical structures in a manner similar to that previously described. The
outer sheath 130 can be pulled back to allow the electrode to expand outwardly from the catheter and into apposition with the wall of the lumen being treated. The two sets ofelectrodes outer sheath 130 is pushed forward to force the expanded electrodes back to an unexpanded condition. The catheter can then be removed from the patient, or another section of the vein can be treated. - The description of the component parts discussed above are for a catheter to be used in a vein ranging in size from 3 mm (0.12 in) to 10 mm (0.39 in) in diameter. It is to be understood that these dimensions do not limit the scope of the invention and are merely exemplary in nature. The dimensions of the component parts may be changed to configure a catheter that may used in various-sized veins or other anatomical structures.
- Referring now to
FIG. 12 , there is shown a partial cross-section view of the catheter ofFIGS. 10 and 11 . Two pluralities ofelectrodes first plurality 120 being indicated bynumeral 124 and the electrodes of thesecond plurality 122 being indicated bynumeral 150. Each electrode is formed from an electrically-conductive electrode lead inner tube 156 includes alumen 158 through which fluid may flow for flush or other purposes, or through which a guide wire may be positioned. Ahypotube 160 is positioned over the inner tube and layers ofinsulation 162 are mounted over the hypotube. Thefirst plurality 120 of electrode leads 152 extend proximally to afirst mounting ring 164 to which all are connected. Thesecond plurality 122 of electrode leads 154 extend proximally to asecond mounting ring 166 to which all are connected. Therings Wire conductors - Alternate arrangements are possible and in one, alternating electrodes of a particular plurality are connected to two different rings. Each ring is separately connected to the power source and the polarities of the rings may therefore be made different to establish a bipolar approach within the plurality. One electrode may be a “+” polarity while the two adjacent electrodes may be a “−” polarity. In this case then, there would be a total of three rings for all electrodes. In another arrangement, both pluralities would have two rings for its respective electrodes with alternating electrodes connected to different rings so that bipolar approaches within each plurality may be established. In this case, there would exist a total of four rings for the two pluralities of electrodes.
- An outer
movable sheath 172 when slid in the distal direction to the point shown inFIG. 12 will cause the electrode leads to contract to the position shown. When slid in the proximal direction a sufficient distance, thesheath 172 acts as a deployment device in that it will move past the bend (not shown) in each of the electrode leads of thesecond plurality 122 permitting all electrode leads to expand outwardly as shown inFIG. 11 . - The electrode leads are formed of stainless steel in this embodiment and with the thin insulation layer and the outward bend, have enough strength to automatically move outwardly through blood flow (in a venous application) and into apposition with the inner wall of the target tissue. As the inner wall shrinks due to the application of heat by the electrodes, the inner wall will force the electrode leads toward their contracted position but the electrodes will automatically stay in apposition with the inner wall during the entire ligation process due to their outward bends and the material of which they are formed.
- In one embodiment shown in
FIG. 12 , theelectrode 124 includes atemperature sensor 54 and an electrode of the second plurality also includes atemperature sensor 54. Although not shown as such, they are mounted flush with the outer electrode surfaces and their wires protrude inwardly through the electrode and are held in place along the respective leads 152 and 154. In one embodiment, the microprocessor 52 (FIG. 4 ) receives the signals from both temperature sensors, averages those signals and determines the effective temperature at the treatment site based on that average signal. Methods of averaging temperature signals are well known to those skilled in the art and no further description is provided here. - Although described above as positively charged, negatively charged, or as a positive conductor or negative conductor, these terms are used for purposes of illustration only. These terms are generally meant to refer to different electrode potentials and are not meant to indicate that any particular voltage is positive or negative. Furthermore, other types of energy such as light energy from fiber optics can be used to create a thermal effect in the hollow anatomical structure undergoing treatment. Additionally, although the electrodes and leads have been described as protruding from a distal orifice in the catheter, they may be expanded by other means and in other configurations. In another embodiment, the leads may be deployed by an inner pull wire, hydraulics, or magnetic fields.
- The benefits of tumescence would include locally anesthetizing the treatment area for a prolonged period of time and insulating most of the surrounding tissue and nerves from the damage of heat conducting from the treated vein. An additional benefit of the vasoconstriction induced by the Epinephrine would be that the constricted blood vessels would limit how fast the body absorbed the Lidocaine thus keeping the level of Lidocaine absorbed below the toxicity level. Also, as mentioned supra, extended applications of energy have a greater possibility of increasing the temperature of the blood to an unacceptable level and may result in a significant amount of heat-induced coagulum forming on the electrode and in the vein which is not desirable. Using a tumescent anesthesia compression technique, including the administration of vasoconstrictive drugs, would aid in preventing this problem by exsanguinating the vein.
- Although described above in terms of a vein, the concepts are generally applicable to other hollow anatomical structures in the body as well. The above description has been generally confined to veins in consideration of avoiding unnecessary repetition.
- While several particular forms of the invention have been illustrated and described, it will be apparent that various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited, except as by the appended claims.
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/140,219 US20080249519A1 (en) | 1997-09-11 | 2008-06-16 | Method and apparatus for applying energy to biological tissue including the use of tumescent tissue compression |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/927,251 US6200312B1 (en) | 1997-09-11 | 1997-09-11 | Expandable vein ligator catheter having multiple electrode leads |
US09/138,472 US6179832B1 (en) | 1997-09-11 | 1998-08-21 | Expandable catheter having two sets of electrodes |
US09/267,127 US6258084B1 (en) | 1997-09-11 | 1999-03-10 | Method for applying energy to biological tissue including the use of tumescent tissue compression |
US09/899,885 US6752803B2 (en) | 1997-09-11 | 2001-07-06 | Method and apparatus for applying energy to biological tissue including the use of tumescent tissue compression |
US10/872,646 US7396355B2 (en) | 1997-09-11 | 2004-06-21 | Method and apparatus for applying energy to biological tissue including the use of tumescent tissue compression |
US12/140,219 US20080249519A1 (en) | 1997-09-11 | 2008-06-16 | Method and apparatus for applying energy to biological tissue including the use of tumescent tissue compression |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/872,646 Continuation US7396355B2 (en) | 1997-09-11 | 2004-06-21 | Method and apparatus for applying energy to biological tissue including the use of tumescent tissue compression |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080249519A1 true US20080249519A1 (en) | 2008-10-09 |
Family
ID=25454471
Family Applications (9)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/927,251 Expired - Lifetime US6200312B1 (en) | 1997-09-11 | 1997-09-11 | Expandable vein ligator catheter having multiple electrode leads |
US08/958,766 Expired - Lifetime US6165172A (en) | 1997-09-11 | 1997-10-26 | Expandable vein ligator catheter and method of use |
US09/267,756 Expired - Lifetime US6237606B1 (en) | 1997-09-11 | 1999-03-10 | Method of applying energy to tissue with expandable ligator catheter having multiple electrode leads |
US09/866,517 Expired - Lifetime US6769433B2 (en) | 1997-09-11 | 2001-05-25 | Expandable vein ligator catheter having multiple electrode leads, and method |
US10/900,563 Expired - Fee Related US7406970B2 (en) | 1997-09-11 | 2004-07-28 | Method of using expandable vein ligator catheter having multiple electrode leads |
US12/126,727 Expired - Fee Related US7901402B2 (en) | 1997-09-11 | 2008-05-23 | Expandable catheter having two sets of electrodes |
US12/140,219 Abandoned US20080249519A1 (en) | 1997-09-11 | 2008-06-16 | Method and apparatus for applying energy to biological tissue including the use of tumescent tissue compression |
US12/181,277 Expired - Fee Related US8679110B2 (en) | 1997-09-11 | 2008-07-28 | Expandable vein ligator catheter having multiple electrode leads, and method |
US12/258,358 Expired - Fee Related US8267931B2 (en) | 1997-09-11 | 2008-10-24 | Method of ligating hollow anatomical structures |
Family Applications Before (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/927,251 Expired - Lifetime US6200312B1 (en) | 1997-09-11 | 1997-09-11 | Expandable vein ligator catheter having multiple electrode leads |
US08/958,766 Expired - Lifetime US6165172A (en) | 1997-09-11 | 1997-10-26 | Expandable vein ligator catheter and method of use |
US09/267,756 Expired - Lifetime US6237606B1 (en) | 1997-09-11 | 1999-03-10 | Method of applying energy to tissue with expandable ligator catheter having multiple electrode leads |
US09/866,517 Expired - Lifetime US6769433B2 (en) | 1997-09-11 | 2001-05-25 | Expandable vein ligator catheter having multiple electrode leads, and method |
US10/900,563 Expired - Fee Related US7406970B2 (en) | 1997-09-11 | 2004-07-28 | Method of using expandable vein ligator catheter having multiple electrode leads |
US12/126,727 Expired - Fee Related US7901402B2 (en) | 1997-09-11 | 2008-05-23 | Expandable catheter having two sets of electrodes |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/181,277 Expired - Fee Related US8679110B2 (en) | 1997-09-11 | 2008-07-28 | Expandable vein ligator catheter having multiple electrode leads, and method |
US12/258,358 Expired - Fee Related US8267931B2 (en) | 1997-09-11 | 2008-10-24 | Method of ligating hollow anatomical structures |
Country Status (3)
Country | Link |
---|---|
US (9) | US6200312B1 (en) |
KR (1) | KR100451273B1 (en) |
IL (1) | IL135008A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060189967A1 (en) * | 2005-02-21 | 2006-08-24 | Leonardo Masotti | Device, a catheter, and a method for the curative treatment of varicose veins |
US20070100329A1 (en) * | 2003-09-30 | 2007-05-03 | Ceramoptec Industries Inc. | Method for treatment of varices |
US20100330896A1 (en) * | 2009-06-25 | 2010-12-30 | Fujitsu Limited | Air conditioning installation and control method |
US7901402B2 (en) | 1997-09-11 | 2011-03-08 | Tyco Healthcare Group, Lp | Expandable catheter having two sets of electrodes |
US20140236225A1 (en) * | 2013-02-21 | 2014-08-21 | St. Jude Medical Puerto Rico Llc | Bioadhesive delivery systems and methods for vascular closure |
US20150157851A1 (en) * | 2013-12-05 | 2015-06-11 | Advanced Neuromodulation Systems, Inc. | Medical leads with segmented electrodes and methods of fabrication thereof |
US20170128697A1 (en) * | 2015-11-06 | 2017-05-11 | Kardium Inc. | Medical device systems and methods including safety release, lumen fluid-providing mechanisms, or both |
Families Citing this family (307)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5417210A (en) * | 1992-05-27 | 1995-05-23 | International Business Machines Corporation | System and method for augmentation of endoscopic surgery |
CA2248260C (en) * | 1996-03-05 | 2010-11-16 | Michael D. Laufer | Vascular catheter-based system for heating tissue |
US7604633B2 (en) | 1996-04-12 | 2009-10-20 | Cytyc Corporation | Moisture transport system for contact electrocoagulation |
US7022105B1 (en) * | 1996-05-06 | 2006-04-04 | Novasys Medical Inc. | Treatment of tissue in sphincters, sinuses and orifices |
US8353908B2 (en) * | 1996-09-20 | 2013-01-15 | Novasys Medical, Inc. | Treatment of tissue in sphincters, sinuses, and orifices |
CA2282546C (en) * | 1997-03-04 | 2008-04-01 | Vnus Medical Technologies, Inc. | Method and apparatus for treating venous insufficiency using directionally applied energy |
US9023031B2 (en) | 1997-08-13 | 2015-05-05 | Verathon Inc. | Noninvasive devices, methods, and systems for modifying tissues |
US8551082B2 (en) | 1998-05-08 | 2013-10-08 | Cytyc Surgical Products | Radio-frequency generator for powering an ablation device |
US6626899B2 (en) | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
US6402745B1 (en) * | 2000-02-23 | 2002-06-11 | Peter J. Wilk | Intravenous whip electrode for vein ablation |
US20040034303A1 (en) * | 2000-06-16 | 2004-02-19 | Korotko Joseph R. | Blood-flow-occluding, temperature-sensing catheters and methods of use |
US6712771B2 (en) * | 2000-06-16 | 2004-03-30 | Accumed Systems, Inc. | Temperature sensing catheter |
US6669691B1 (en) * | 2000-07-18 | 2003-12-30 | Scimed Life Systems, Inc. | Epicardial myocardial revascularization and denervation methods and apparatus |
US20030120256A1 (en) * | 2001-07-03 | 2003-06-26 | Syntheon, Llc | Methods and apparatus for sclerosing the wall of a varicose vein |
US20050107738A1 (en) * | 2000-07-21 | 2005-05-19 | Slater Charles R. | Occludable intravascular catheter for drug delivery and method of using the same |
US20050113798A1 (en) * | 2000-07-21 | 2005-05-26 | Slater Charles R. | Methods and apparatus for treating the interior of a blood vessel |
US7077836B2 (en) * | 2000-07-21 | 2006-07-18 | Vein Rx, Inc. | Methods and apparatus for sclerosing the wall of a varicose vein |
US7789876B2 (en) * | 2000-08-14 | 2010-09-07 | Tyco Healthcare Group, Lp | Method and apparatus for positioning a catheter relative to an anatomical junction |
US7306591B2 (en) | 2000-10-02 | 2007-12-11 | Novasys Medical, Inc. | Apparatus and methods for treating female urinary incontinence |
US6712815B2 (en) | 2001-01-16 | 2004-03-30 | Novacept, Inc. | Apparatus and method for treating venous reflux |
US20040015159A1 (en) * | 2001-07-03 | 2004-01-22 | Syntheon, Llc | Methods and apparatus for treating the wall of a blood vessel with electromagnetic energy |
US8974446B2 (en) | 2001-10-11 | 2015-03-10 | St. Jude Medical, Inc. | Ultrasound ablation apparatus with discrete staggered ablation zones |
US20030073987A1 (en) * | 2001-10-16 | 2003-04-17 | Olympus Optical Co., Ltd. | Treating apparatus and treating device for treating living-body tissue |
US6669693B2 (en) | 2001-11-13 | 2003-12-30 | Mayo Foundation For Medical Education And Research | Tissue ablation device and methods of using |
AU2002364573A1 (en) * | 2001-12-14 | 2004-07-09 | The General Hospital Corporation | Dynamic cannula |
EP1334699A1 (en) * | 2002-02-11 | 2003-08-13 | Led S.p.A. | Apparatus for electrosurgery |
US7074220B2 (en) * | 2002-04-03 | 2006-07-11 | Thomas J. Fogarty | Methods and systems for vein harvesting and fistula creation |
US20040049208A1 (en) * | 2002-04-03 | 2004-03-11 | Thomas Fogarty, M.D. | Methods and systems for vein harvesting and fistula creation |
US6551314B1 (en) | 2002-04-03 | 2003-04-22 | Thomas J. Fogarty | Methods and systems for vein harvesting |
US9440046B2 (en) | 2002-04-04 | 2016-09-13 | Angiodynamics, Inc. | Venous insufficiency treatment method |
US7163533B2 (en) * | 2002-04-04 | 2007-01-16 | Angiodynamics, Inc. | Vascular treatment device and method |
US8150519B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US6752767B2 (en) | 2002-04-16 | 2004-06-22 | Vivant Medical, Inc. | Localization element with energized tip |
US7837627B1 (en) * | 2002-05-10 | 2010-11-23 | Rick L Pruter | Sheath apparatus for guiding needles for use with a medical ultrasound transceiver |
US7572257B2 (en) * | 2002-06-14 | 2009-08-11 | Ncontact Surgical, Inc. | Vacuum coagulation and dissection probes |
US6893442B2 (en) * | 2002-06-14 | 2005-05-17 | Ablatrics, Inc. | Vacuum coagulation probe for atrial fibrillation treatment |
US8235990B2 (en) * | 2002-06-14 | 2012-08-07 | Ncontact Surgical, Inc. | Vacuum coagulation probes |
US7063698B2 (en) * | 2002-06-14 | 2006-06-20 | Ncontact Surgical, Inc. | Vacuum coagulation probes |
US9439714B2 (en) | 2003-04-29 | 2016-09-13 | Atricure, Inc. | Vacuum coagulation probes |
US8864754B2 (en) | 2002-07-10 | 2014-10-21 | Angiodynamics, Inc. | Device and method for endovascular treatment for causing closure of a blood vessel |
US7273478B2 (en) * | 2002-07-10 | 2007-09-25 | Angiodynamics, Inc. | Endovascular treatment device having a fiber tip spacer |
US7769427B2 (en) * | 2002-07-16 | 2010-08-03 | Magnetics, Inc. | Apparatus and method for catheter guidance control and imaging |
US8361067B2 (en) | 2002-09-30 | 2013-01-29 | Relievant Medsystems, Inc. | Methods of therapeutically heating a vertebral body to treat back pain |
US6907884B2 (en) | 2002-09-30 | 2005-06-21 | Depay Acromed, Inc. | Method of straddling an intraosseous nerve |
US8613744B2 (en) | 2002-09-30 | 2013-12-24 | Relievant Medsystems, Inc. | Systems and methods for navigating an instrument through bone |
US7258690B2 (en) * | 2003-03-28 | 2007-08-21 | Relievant Medsystems, Inc. | Windowed thermal ablation probe |
US8808284B2 (en) | 2008-09-26 | 2014-08-19 | Relievant Medsystems, Inc. | Systems for navigating an instrument through bone |
US7223266B2 (en) * | 2003-02-04 | 2007-05-29 | Cardiodex Ltd. | Methods and apparatus for hemostasis following arterial catheterization |
US20040167467A1 (en) * | 2003-02-21 | 2004-08-26 | Kent Harrison | Delivering cooled fluid to sites inside the body |
US7104985B2 (en) * | 2003-03-06 | 2006-09-12 | Martinelli Michael A | Apparatus and method for causing selective necrosis of abnormal cells |
US6964661B2 (en) * | 2003-04-02 | 2005-11-15 | Boston Scientific Scimed, Inc. | Endovenous ablation mechanism with feedback control |
ES2400508T3 (en) * | 2003-07-11 | 2013-04-10 | S.D.M.H. Pty. Ltd. | Thermal ablation of biological tissue |
US7291146B2 (en) | 2003-09-12 | 2007-11-06 | Minnow Medical, Inc. | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US7280863B2 (en) * | 2003-10-20 | 2007-10-09 | Magnetecs, Inc. | System and method for radar-assisted catheter guidance and control |
US7326195B2 (en) | 2003-11-18 | 2008-02-05 | Boston Scientific Scimed, Inc. | Targeted cooling of tissue within a body |
WO2005053547A2 (en) | 2003-11-28 | 2005-06-16 | Cook Incorporated | Vascular occlusion methods, systems and devices |
EP1709924B1 (en) * | 2004-01-27 | 2018-10-31 | Japan Lifeline Co., Ltd | Ablation catheter |
JP4755638B2 (en) | 2004-03-05 | 2011-08-24 | ハンセン メディカル,インク. | Robotic guide catheter system |
US8052636B2 (en) * | 2004-03-05 | 2011-11-08 | Hansen Medical, Inc. | Robotic catheter system and methods |
US8021326B2 (en) * | 2004-03-05 | 2011-09-20 | Hansen Medical, Inc. | Instrument driver for robotic catheter system |
US7974681B2 (en) * | 2004-03-05 | 2011-07-05 | Hansen Medical, Inc. | Robotic catheter system |
US7976539B2 (en) * | 2004-03-05 | 2011-07-12 | Hansen Medical, Inc. | System and method for denaturing and fixing collagenous tissue |
GB2451785B (en) * | 2004-03-29 | 2009-03-25 | Cook Biotech Inc | Medical graft products with differing regions |
EP2368512A1 (en) * | 2004-05-17 | 2011-09-28 | C.R. Bard, Inc. | Irrigated catheter |
US8005537B2 (en) * | 2004-07-19 | 2011-08-23 | Hansen Medical, Inc. | Robotically controlled intravascular tissue injection system |
US7824408B2 (en) * | 2004-08-05 | 2010-11-02 | Tyco Healthcare Group, Lp | Methods and apparatus for coagulating and/or constricting hollow anatomical structures |
EP1781354A4 (en) * | 2004-08-19 | 2008-04-09 | Vein Rx Inc | An occludable intravascular catheter for drug delivery and method of using the same |
AU2005278539A1 (en) * | 2004-09-01 | 2006-03-09 | Jms Co., Ltd. | Varicosis treatment apparatus |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US9974607B2 (en) | 2006-10-18 | 2018-05-22 | Vessix Vascular, Inc. | Inducing desirable temperature effects on body tissue |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US7731712B2 (en) | 2004-12-20 | 2010-06-08 | Cytyc Corporation | Method and system for transcervical tubal occlusion |
KR20060072734A (en) * | 2004-12-23 | 2006-06-28 | 두산인프라코어 주식회사 | Appareatus for supplying compressed air of construction heavy equipments |
EP1835958A1 (en) * | 2005-01-14 | 2007-09-26 | Vein RX Inc. | Valve system for a medical device having an inflatable member |
US7972354B2 (en) | 2005-01-25 | 2011-07-05 | Tyco Healthcare Group Lp | Method and apparatus for impeding migration of an implanted occlusive structure |
US7625372B2 (en) * | 2005-02-23 | 2009-12-01 | Vnus Medical Technologies, Inc. | Methods and apparatus for coagulating and/or constricting hollow anatomical structures |
WO2006105121A2 (en) | 2005-03-28 | 2006-10-05 | Minnow Medical, Llc | Intraluminal electrical tissue characterization and tuned rf energy for selective treatment of atheroma and other target tissues |
US7674260B2 (en) | 2005-04-28 | 2010-03-09 | Cytyc Corporation | Emergency hemostasis device utilizing energy |
US8027714B2 (en) * | 2005-05-27 | 2011-09-27 | Magnetecs, Inc. | Apparatus and method for shaped magnetic field control for catheter, guidance, control, and imaging |
WO2007002304A2 (en) | 2005-06-22 | 2007-01-04 | Vnus Medical Technologies, Inc. | Methods and apparatus for introducing tumescent fluid to body tissue |
EP1906858B1 (en) | 2005-07-01 | 2016-11-16 | Hansen Medical, Inc. | Robotic catheter system |
WO2007008954A2 (en) * | 2005-07-11 | 2007-01-18 | Ablation Frontiers | Low power tissue ablation system |
CN102389332B (en) | 2005-07-21 | 2014-08-27 | 泰科医疗集团有限合伙公司 | Systems and methods for treating a hollow anatomical structure |
EP2662044B1 (en) | 2005-07-21 | 2018-10-31 | Covidien LP | Systems for treating a hollow anatomical structure |
US20070055229A1 (en) * | 2005-09-06 | 2007-03-08 | Kladakis Stephanie M | In tunnel electrode for sealing intracardiac defects |
US7869854B2 (en) * | 2006-02-23 | 2011-01-11 | Magnetecs, Inc. | Apparatus for magnetically deployable catheter with MOSFET sensor and method for mapping and ablation |
US20070244371A1 (en) * | 2006-04-04 | 2007-10-18 | Nguyen Hoa D | Phlebectomy illumination device and methods |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US20080039746A1 (en) | 2006-05-25 | 2008-02-14 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
JP4201037B2 (en) * | 2006-09-14 | 2008-12-24 | ソニー株式会社 | Lens barrel rotation imaging device |
US8486060B2 (en) * | 2006-09-18 | 2013-07-16 | Cytyc Corporation | Power ramping during RF ablation |
US20080071269A1 (en) * | 2006-09-18 | 2008-03-20 | Cytyc Corporation | Curved Endoscopic Medical Device |
EP2954868A1 (en) | 2006-10-18 | 2015-12-16 | Vessix Vascular, Inc. | Tuned rf energy and electrical tissue characterization for selective treatment of target tissues |
AU2007310991B2 (en) | 2006-10-18 | 2013-06-20 | Boston Scientific Scimed, Inc. | System for inducing desirable temperature effects on body tissue |
WO2008057118A1 (en) * | 2006-11-09 | 2008-05-15 | Ncontact Surgical, Inc. | Vacuum coagulation probes |
US7846160B2 (en) | 2006-12-21 | 2010-12-07 | Cytyc Corporation | Method and apparatus for sterilization |
WO2008097853A2 (en) | 2007-02-02 | 2008-08-14 | Hansen Medical, Inc. | Mounting support assembly for suspending a medical instrument driver above an operating table |
US20080200873A1 (en) * | 2007-02-16 | 2008-08-21 | Alejandro Espinosa | Methods and Apparatus for Infusing the Interior of a Blood Vessel |
US8496653B2 (en) | 2007-04-23 | 2013-07-30 | Boston Scientific Scimed, Inc. | Thrombus removal |
CN101795635B (en) | 2007-04-27 | 2012-06-06 | 泰科医疗集团有限合伙公司 | Systems and methods for treating hollow anatomical structures |
US8579886B2 (en) * | 2007-05-01 | 2013-11-12 | Covidien Lp | Accordion style cable stand-off |
AU2008202055A1 (en) * | 2007-05-17 | 2008-12-04 | Cathrx Ltd | A catheter sheath |
US20080297287A1 (en) * | 2007-05-30 | 2008-12-04 | Magnetecs, Inc. | Magnetic linear actuator for deployable catheter tools |
KR100898413B1 (en) | 2007-06-15 | 2009-05-21 | 중앙대학교 산학협력단 | Catheter system |
AU2008277251A1 (en) * | 2007-07-13 | 2009-01-22 | Yigal Gat | Diagnosis and treatment of varicocele and prostate disorders |
US20090018486A1 (en) * | 2007-07-13 | 2009-01-15 | Menachem Goren | Diagnosis and treatment of vericocele and prostate disorders |
US20100204639A1 (en) * | 2007-07-13 | 2010-08-12 | Yigal Gat | Diagnosis and treatment of varicocele and prostate disorders |
US8280525B2 (en) * | 2007-11-16 | 2012-10-02 | Vivant Medical, Inc. | Dynamically matched microwave antenna for tissue ablation |
US8292880B2 (en) | 2007-11-27 | 2012-10-23 | Vivant Medical, Inc. | Targeted cooling of deployable microwave antenna |
EP2231060B1 (en) * | 2007-12-10 | 2015-05-27 | Medtronic Ablation Frontiers LLC | Ablation catheter |
US8157747B2 (en) * | 2008-02-15 | 2012-04-17 | Lary Research & Development, Llc | Single-use indicator for a surgical instrument and a surgical instrument incorporating same |
US20090248011A1 (en) * | 2008-02-28 | 2009-10-01 | Hlavka Edwin J | Chronic venous insufficiency treatment |
US8197475B2 (en) * | 2008-03-17 | 2012-06-12 | Medtronic Vascular, Inc. | Method and structure for ameliorating side-effects of performing in situ fenestration using a plasma RF catheter |
WO2009141810A2 (en) * | 2008-05-23 | 2009-11-26 | Oscillon Ltd | Method and device for recanalization of total occlusions |
US9770297B2 (en) * | 2008-06-04 | 2017-09-26 | Covidien Lp | Energy devices and methods for treating hollow anatomical structures |
CN102112063A (en) * | 2008-06-06 | 2011-06-29 | 瓦里克斯医疗公司 | Vein therapy device and method |
EP3406210A1 (en) | 2008-09-26 | 2018-11-28 | Relievant Medsystems, Inc. | Systems and for navigating an instrument through bone |
US10028753B2 (en) | 2008-09-26 | 2018-07-24 | Relievant Medsystems, Inc. | Spine treatment kits |
US9795442B2 (en) | 2008-11-11 | 2017-10-24 | Shifamed Holdings, Llc | Ablation catheters |
EP2370015B1 (en) * | 2008-11-11 | 2016-12-21 | Shifamed Holdings, LLC | Low profile electrode assembly |
JP5307900B2 (en) | 2008-11-17 | 2013-10-02 | べシックス・バスキュラー・インコーポレイテッド | Selective energy storage without knowledge of organizational topography |
US8317746B2 (en) * | 2008-11-20 | 2012-11-27 | Hansen Medical, Inc. | Automated alignment |
US8457714B2 (en) | 2008-11-25 | 2013-06-04 | Magnetecs, Inc. | System and method for a catheter impedance seeking device |
US8974453B2 (en) | 2008-12-02 | 2015-03-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Irrigated ablation catheter having a flexible manifold |
US20100198209A1 (en) * | 2009-01-30 | 2010-08-05 | Tartaglia Joseph M | Hemorrhoid Therapy and Method |
US8632533B2 (en) * | 2009-02-23 | 2014-01-21 | Medtronic Advanced Energy Llc | Fluid-assisted electrosurgical device |
US20100217250A1 (en) * | 2009-02-24 | 2010-08-26 | Sierra Surgical Technologies | Methods and systems for controlled thermal tissue |
US9254123B2 (en) | 2009-04-29 | 2016-02-09 | Hansen Medical, Inc. | Flexible and steerable elongate instruments with shape control and support elements |
US20100280328A1 (en) * | 2009-05-01 | 2010-11-04 | Tyco Healthcare Group, Lp | Methods and systems for illumination during phlebectomy procedures |
US8551096B2 (en) | 2009-05-13 | 2013-10-08 | Boston Scientific Scimed, Inc. | Directional delivery of energy and bioactives |
EP2445568B1 (en) | 2009-06-24 | 2020-09-23 | Kalila Medical, Inc. | Steerable medical delivery devices |
US20110112396A1 (en) | 2009-11-09 | 2011-05-12 | Magnetecs, Inc. | System and method for targeting catheter electrodes |
US8979839B2 (en) | 2009-11-13 | 2015-03-17 | St. Jude Medical, Inc. | Assembly of staggered ablation elements |
US8882759B2 (en) * | 2009-12-18 | 2014-11-11 | Covidien Lp | Microwave ablation system with dielectric temperature probe |
US9616246B2 (en) * | 2010-01-04 | 2017-04-11 | Covidien Lp | Apparatus and methods for treating hollow anatomical structures |
US8568404B2 (en) | 2010-02-19 | 2013-10-29 | Covidien Lp | Bipolar electrode probe for ablation monitoring |
EP2550040A4 (en) | 2010-03-24 | 2014-03-26 | Shifamed Holdings Llc | Intravascular tissue disruption |
EP2555699B1 (en) | 2010-04-09 | 2019-04-03 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
EP2563256B1 (en) * | 2010-04-26 | 2019-08-28 | Medtronic Holding Company Sàrl | Electrosurgical device |
WO2011143468A2 (en) | 2010-05-12 | 2011-11-17 | Shifamed, Llc | Low profile electrode assembly |
US9655677B2 (en) | 2010-05-12 | 2017-05-23 | Shifamed Holdings, Llc | Ablation catheters including a balloon and electrodes |
US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US9138289B2 (en) * | 2010-06-28 | 2015-09-22 | Medtronic Advanced Energy Llc | Electrode sheath for electrosurgical device |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US20120029505A1 (en) * | 2010-07-30 | 2012-02-02 | Jenson Mark L | Self-Leveling Electrode Sets for Renal Nerve Ablation |
US20120071894A1 (en) | 2010-09-17 | 2012-03-22 | Tanner Neal A | Robotic medical systems and methods |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9220558B2 (en) * | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
US20120191079A1 (en) | 2011-01-20 | 2012-07-26 | Hansen Medical, Inc. | System and method for endoluminal and translumenal therapy |
EP2677961A4 (en) | 2011-02-24 | 2014-10-29 | Eximo Medical Ltd | Hybrid catheter for vascular intervention |
JP5759615B2 (en) | 2011-04-08 | 2015-08-05 | コヴィディエン リミテッド パートナーシップ | Iontophoretic catheter system and method for renal sympathetic denervation and iontophoretic drug delivery |
EP2701623B1 (en) | 2011-04-25 | 2016-08-17 | Medtronic Ardian Luxembourg S.à.r.l. | Apparatus related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls |
CA2833387A1 (en) | 2011-05-03 | 2012-11-08 | Shifamed Holdings, Llc | Steerable delivery sheaths |
US8909316B2 (en) | 2011-05-18 | 2014-12-09 | St. Jude Medical, Cardiology Division, Inc. | Apparatus and method of assessing transvascular denervation |
US9055951B2 (en) * | 2011-05-23 | 2015-06-16 | Covidien Lp | Endovascular tissue removal device |
US8992513B2 (en) | 2011-06-30 | 2015-03-31 | Angiodynamics, Inc | Endovascular plasma treatment device and method of use |
AU2012283908B2 (en) | 2011-07-20 | 2017-02-16 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
WO2013016203A1 (en) | 2011-07-22 | 2013-01-31 | Boston Scientific Scimed, Inc. | Nerve modulation system with a nerve modulation element positionable in a helical guide |
US20130030363A1 (en) | 2011-07-29 | 2013-01-31 | Hansen Medical, Inc. | Systems and methods utilizing shape sensing fibers |
US9427579B2 (en) | 2011-09-29 | 2016-08-30 | Pacesetter, Inc. | System and method for performing renal denervation verification |
WO2013055826A1 (en) | 2011-10-10 | 2013-04-18 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
EP2765940B1 (en) | 2011-10-11 | 2015-08-26 | Boston Scientific Scimed, Inc. | Off-wall electrode device for nerve modulation |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
WO2013059202A1 (en) | 2011-10-18 | 2013-04-25 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
US9162046B2 (en) | 2011-10-18 | 2015-10-20 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
CN108095821B (en) | 2011-11-08 | 2021-05-25 | 波士顿科学西美德公司 | Orifice renal nerve ablation |
US9119600B2 (en) | 2011-11-15 | 2015-09-01 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
EP2793690B1 (en) | 2011-12-23 | 2021-04-07 | Vessix Vascular, Inc. | Expandable balloon or an electrode pad with a heat sensing device |
US9433760B2 (en) | 2011-12-28 | 2016-09-06 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
AU2012362524B2 (en) | 2011-12-30 | 2018-12-13 | Relievant Medsystems, Inc. | Systems and methods for treating back pain |
US8934988B2 (en) | 2012-03-16 | 2015-01-13 | St. Jude Medical Ab | Ablation stent with meander structure |
US8403927B1 (en) | 2012-04-05 | 2013-03-26 | William Bruce Shingleton | Vasectomy devices and methods |
US8961550B2 (en) | 2012-04-17 | 2015-02-24 | Indian Wells Medical, Inc. | Steerable endoluminal punch |
US9113929B2 (en) | 2012-04-19 | 2015-08-25 | St. Jude Medical, Cardiology Division, Inc. | Non-electric field renal denervation electrode |
US10660703B2 (en) | 2012-05-08 | 2020-05-26 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US10321946B2 (en) | 2012-08-24 | 2019-06-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices with weeping RF ablation balloons |
US10588691B2 (en) | 2012-09-12 | 2020-03-17 | Relievant Medsystems, Inc. | Radiofrequency ablation of tissue within a vertebral body |
US9173696B2 (en) | 2012-09-17 | 2015-11-03 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
US10835305B2 (en) | 2012-10-10 | 2020-11-17 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
EP3598952A3 (en) | 2012-11-05 | 2020-04-15 | Relievant Medsystems, Inc. | Systems and methods for creating curved paths through bone and modulating nerves within the bone |
US20140148673A1 (en) | 2012-11-28 | 2014-05-29 | Hansen Medical, Inc. | Method of anchoring pullwire directly articulatable region in catheter |
RU2649527C2 (en) * | 2013-02-05 | 2018-04-03 | Хандок Инк. | Nerve block catheter |
KR101370048B1 (en) * | 2013-02-05 | 2014-03-04 | 주식회사 한독 | Catheter for denervation |
US9179997B2 (en) | 2013-03-06 | 2015-11-10 | St. Jude Medical, Cardiology Division, Inc. | Thermochromic polyvinyl alcohol based hydrogel artery |
US9877707B2 (en) | 2013-03-07 | 2018-01-30 | Kyphon SÀRL | Systems and methods for track coagulation |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US10328238B2 (en) | 2013-03-12 | 2019-06-25 | St. Jude Medical, Cardiology Division, Inc. | Catheter system |
EP2777739B1 (en) | 2013-03-12 | 2018-09-05 | St. Jude Medical, Cardiology Division, Inc. | Catheter system |
EP2777741A3 (en) | 2013-03-12 | 2015-01-21 | St. Jude Medical, Cardiology Division, Inc. | Catheter system |
US9510902B2 (en) | 2013-03-13 | 2016-12-06 | St. Jude Medical, Cardiology Division, Inc. | Ablation catheters and systems including rotational monitoring means |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US8876813B2 (en) | 2013-03-14 | 2014-11-04 | St. Jude Medical, Inc. | Methods, systems, and apparatus for neural signal detection |
US9131982B2 (en) | 2013-03-14 | 2015-09-15 | St. Jude Medical, Cardiology Division, Inc. | Mediguide-enabled renal denervation system for ensuring wall contact and mapping lesion locations |
US20140277334A1 (en) | 2013-03-14 | 2014-09-18 | Hansen Medical, Inc. | Active drives for robotic catheter manipulators |
US9326822B2 (en) | 2013-03-14 | 2016-05-03 | Hansen Medical, Inc. | Active drives for robotic catheter manipulators |
US9179973B2 (en) | 2013-03-15 | 2015-11-10 | St. Jude Medical, Cardiology Division, Inc. | Feedback systems and methods for renal denervation utilizing balloon catheter |
CN105473090B (en) | 2013-03-15 | 2019-05-03 | 波士顿科学国际有限公司 | Rebuild the method and device of the tissue of body passage or the tissue of neighbouring body passage |
CN105228546B (en) | 2013-03-15 | 2017-11-14 | 波士顿科学国际有限公司 | Utilize the impedance-compensated medicine equipment and method that are used to treat hypertension |
US9186212B2 (en) | 2013-03-15 | 2015-11-17 | St. Jude Medical, Cardiology Division, Inc. | Feedback systems and methods utilizing two or more sites along denervation catheter |
US9408669B2 (en) | 2013-03-15 | 2016-08-09 | Hansen Medical, Inc. | Active drive mechanism with finite range of motion |
US20140276936A1 (en) | 2013-03-15 | 2014-09-18 | Hansen Medical, Inc. | Active drive mechanism for simultaneous rotation and translation |
US20140276767A1 (en) | 2013-03-15 | 2014-09-18 | St. Jude Medical, Cardiology Division, Inc. | Ablation system, methods, and controllers |
US9974477B2 (en) | 2013-03-15 | 2018-05-22 | St. Jude Medical, Cardiology Division, Inc. | Quantification of renal denervation via alterations in renal blood flow pre/post ablation |
EP3692906B1 (en) | 2013-03-15 | 2024-01-10 | Medtronic Holding Company Sàrl | A system for treating tissue |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
WO2014150425A1 (en) | 2013-03-15 | 2014-09-25 | St. Jude Medical, Cardiology Division, Inc. | Multi-electrode ablation system with a controller for determining a thermal gain of each electrode |
US10098694B2 (en) | 2013-04-08 | 2018-10-16 | Apama Medical, Inc. | Tissue ablation and monitoring thereof |
US10349824B2 (en) | 2013-04-08 | 2019-07-16 | Apama Medical, Inc. | Tissue mapping and visualization systems |
CN105228547B (en) | 2013-04-08 | 2019-05-14 | 阿帕玛医疗公司 | Cardiac ablation catheter |
US10350002B2 (en) | 2013-04-25 | 2019-07-16 | St. Jude Medical, Cardiology Division, Inc. | Electrode assembly for catheter system |
JP2016523147A (en) | 2013-06-21 | 2016-08-08 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Renal denervation balloon catheter with a riding-type electrode support |
EP3010436A1 (en) | 2013-06-21 | 2016-04-27 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
US9872728B2 (en) | 2013-06-28 | 2018-01-23 | St. Jude Medical, Cardiology Division, Inc. | Apparatuses and methods for affixing electrodes to an intravascular balloon |
US9833283B2 (en) | 2013-07-01 | 2017-12-05 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US20150011991A1 (en) | 2013-07-03 | 2015-01-08 | St. Jude Medical, Cardiology Division, Inc. | Electrode Assembly For Catheter System |
WO2015006480A1 (en) | 2013-07-11 | 2015-01-15 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation |
WO2015006573A1 (en) | 2013-07-11 | 2015-01-15 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
US9925001B2 (en) | 2013-07-19 | 2018-03-27 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
CN105555220B (en) | 2013-07-22 | 2019-05-17 | 波士顿科学国际有限公司 | Medical instrument for renal nerve ablation |
US10695124B2 (en) | 2013-07-22 | 2020-06-30 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
US9724151B2 (en) | 2013-08-08 | 2017-08-08 | Relievant Medsystems, Inc. | Modulating nerves within bone using bone fasteners |
EP3035879A1 (en) | 2013-08-22 | 2016-06-29 | Boston Scientific Scimed, Inc. | Flexible circuit having improved adhesion to a renal nerve modulation balloon |
EP3041425B1 (en) | 2013-09-04 | 2022-04-13 | Boston Scientific Scimed, Inc. | Radio frequency (rf) balloon catheter having flushing and cooling capability |
US10952790B2 (en) | 2013-09-13 | 2021-03-23 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US9962223B2 (en) | 2013-10-15 | 2018-05-08 | Boston Scientific Scimed, Inc. | Medical device balloon |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
EP3057521B1 (en) | 2013-10-18 | 2020-03-25 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires |
USD774043S1 (en) | 2013-10-23 | 2016-12-13 | St. Jude Medical, Cardiology Division, Inc. | Display screen with graphical user interface for ablation generator |
USD747491S1 (en) | 2013-10-23 | 2016-01-12 | St. Jude Medical, Cardiology Division, Inc. | Ablation generator |
US10856936B2 (en) | 2013-10-23 | 2020-12-08 | St. Jude Medical, Cardiology Division, Inc. | Electrode assembly for catheter system including thermoplastic-based struts |
USD914883S1 (en) | 2013-10-23 | 2021-03-30 | St. Jude Medical, Cardiology Division, Inc. | Ablation generator |
EP3060151A1 (en) | 2013-10-24 | 2016-08-31 | St. Jude Medical, Cardiology Division, Inc. | Flexible catheter shaft and method of manufacture |
US10034705B2 (en) | 2013-10-24 | 2018-07-31 | St. Jude Medical, Cardiology Division, Inc. | High strength electrode assembly for catheter system including novel electrode |
EP3060285A1 (en) | 2013-10-24 | 2016-08-31 | St. Jude Medical, Cardiology Division, Inc. | Flexible catheter shaft and method of manufacture |
JP2016534842A (en) | 2013-10-25 | 2016-11-10 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Embedded thermocouples in denervation flex circuits |
US10420604B2 (en) | 2013-10-28 | 2019-09-24 | St. Jude Medical, Cardiology Division, Inc. | Electrode assembly for catheter system including interlinked struts |
US9861433B2 (en) | 2013-11-05 | 2018-01-09 | St. Jude Medical, Cardiology Division, Inc. | Helical-shaped ablation catheter and methods of use |
US11202671B2 (en) | 2014-01-06 | 2021-12-21 | Boston Scientific Scimed, Inc. | Tear resistant flex circuit assembly |
WO2015119890A1 (en) | 2014-02-04 | 2015-08-13 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
JP2015181705A (en) * | 2014-03-24 | 2015-10-22 | テルモ株式会社 | treatment device |
EP3875139A1 (en) | 2014-03-26 | 2021-09-08 | Venclose, Inc. | Venous disease treatment |
US10046140B2 (en) | 2014-04-21 | 2018-08-14 | Hansen Medical, Inc. | Devices, systems, and methods for controlling active drive systems |
US10398501B2 (en) | 2014-04-24 | 2019-09-03 | St. Jude Medical, Cardiology Division, Inc. | Ablation systems including pulse rate detector and feedback mechanism and methods of use |
US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
WO2015175944A1 (en) * | 2014-05-16 | 2015-11-19 | Gary Long | Methods and apparatus for multi-catheter tissue ablation |
WO2016090122A1 (en) | 2014-12-03 | 2016-06-09 | PAVmed Inc. | Systems and methods for percutaneous division of fibrous structures |
GB201511595D0 (en) * | 2014-12-23 | 2015-08-19 | Whiteley Mark | Medical device for treating a vein |
US10376308B2 (en) | 2015-02-05 | 2019-08-13 | Axon Therapies, Inc. | Devices and methods for treatment of heart failure by splanchnic nerve ablation |
JP6797131B2 (en) | 2015-03-27 | 2020-12-09 | カリラ メディカル インコーポレイテッド | Manipulable medical devices, systems and usage |
JP6820864B2 (en) | 2015-04-24 | 2021-01-27 | カリラ メディカル インコーポレイテッド | Manipulable medical devices, systems and usage |
US10207110B1 (en) | 2015-10-13 | 2019-02-19 | Axon Therapies, Inc. | Devices and methods for treatment of heart failure via electrical modulation of a splanchnic nerve |
JP6866367B2 (en) | 2015-11-09 | 2021-04-28 | カリラ メディカル インコーポレイテッド | Steering assembly and usage of medical devices |
EP3376936B1 (en) | 2015-11-16 | 2024-01-03 | Boston Scientific Scimed, Inc. | Energy delivery devices |
US10441339B2 (en) | 2015-11-17 | 2019-10-15 | Medtronic Holding Company Sárl | Spinal tissue ablation apparatus, system, and method |
US10932861B2 (en) | 2016-01-14 | 2021-03-02 | Auris Health, Inc. | Electromagnetic tracking surgical system and method of controlling the same |
US10932691B2 (en) | 2016-01-26 | 2021-03-02 | Auris Health, Inc. | Surgical tools having electromagnetic tracking components |
US11324554B2 (en) | 2016-04-08 | 2022-05-10 | Auris Health, Inc. | Floating electromagnetic field generator system and method of controlling the same |
EP3241515B1 (en) * | 2016-04-15 | 2019-12-25 | Cook Medical Technologies LLC | Ablation medical device |
CN109414292A (en) | 2016-05-05 | 2019-03-01 | 爱克斯莫医疗有限公司 | Device and method for cutting off and/or melting unwanted tissue |
US11439460B2 (en) | 2016-06-23 | 2022-09-13 | St. Jude Medical, Cardiology Division, Inc. | Catheter system and electrode assembly for intraprocedural evaluation of renal denervation |
US11154354B2 (en) | 2016-07-29 | 2021-10-26 | Axon Therapies, Inc. | Devices, systems, and methods for treatment of heart failure by splanchnic nerve ablation |
DK3288126T3 (en) * | 2016-08-24 | 2020-05-04 | Anord Mardix Databar Busway Ltd | IMPROVEMENTS AND CONCERNING WIRELESS NETWORKS |
US10463439B2 (en) | 2016-08-26 | 2019-11-05 | Auris Health, Inc. | Steerable catheter with shaft load distributions |
US11241559B2 (en) | 2016-08-29 | 2022-02-08 | Auris Health, Inc. | Active drive for guidewire manipulation |
WO2018152271A1 (en) * | 2017-02-15 | 2018-08-23 | Endocages, LLC | Endoscopic assistance devices and methods of use |
WO2019118976A1 (en) | 2017-12-17 | 2019-06-20 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
US11751939B2 (en) | 2018-01-26 | 2023-09-12 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
US10716880B2 (en) * | 2018-06-15 | 2020-07-21 | Incuvate, Llc | Systems and methods for aspiration and monitoring |
KR102084621B1 (en) | 2018-09-19 | 2020-03-04 | 인제대학교 산학협력단 | Catheter having a distal tip converted the shape |
WO2020257763A1 (en) | 2019-06-20 | 2020-12-24 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
US20210137624A1 (en) * | 2019-07-16 | 2021-05-13 | Transenterix Surgical, Inc. | Dynamic scaling of surgical manipulator motion based on surgeon stress parameters |
US11751959B2 (en) * | 2019-07-16 | 2023-09-12 | Asensus Surgical Us, Inc. | Dynamic scaling for a robotic surgical system |
WO2021050767A1 (en) | 2019-09-12 | 2021-03-18 | Relievant Medsystems, Inc. | Systems and methods for tissue modulation |
US11278268B2 (en) | 2019-09-16 | 2022-03-22 | Inventio Lcc | Endoscopy tools and methods of use |
ES2960299T3 (en) | 2020-01-17 | 2024-03-04 | Axon Therapies Inc | Devices for endovascular ablation of a splanchnic nerve |
CN112274205B (en) * | 2020-10-09 | 2021-07-27 | 苏州贝诺医疗器械有限公司 | Multi-hair varicose vein ligation device and using method thereof |
US11937798B2 (en) * | 2021-09-29 | 2024-03-26 | Cilag Gmbh International | Surgical systems with port devices for instrument control |
Family Cites Families (153)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US373339A (en) | 1887-11-15 | Isidobe eskell cliffoed | ||
US373399A (en) | 1887-11-15 | hamilton | ||
US659409A (en) | 1900-08-25 | 1900-10-09 | Charles L Mosher | Electric bipolar dilator. |
US833759A (en) | 1905-07-27 | 1906-10-23 | John D Sourwine | Surgical instrument. |
US985865A (en) | 1910-06-29 | 1911-03-07 | William H Turner Jr | Embalming instrument. |
DE1163993B (en) | 1960-03-23 | 1964-02-27 | Philips Patentverwaltung | Decimeter wave stem radiator for medical treatment |
US3301258A (en) | 1963-10-03 | 1967-01-31 | Medtronic Inc | Method and apparatus for treating varicose veins |
US3557794A (en) | 1968-07-30 | 1971-01-26 | Us Air Force | Arterial dilation device |
US3858586A (en) * | 1971-03-11 | 1975-01-07 | Martin Lessen | Surgical method and electrode therefor |
US4043338A (en) | 1973-04-30 | 1977-08-23 | Ortho Pharmaceutical Corporation | Pharmaceutical formulation applicator device |
DE2324658B2 (en) | 1973-05-16 | 1977-06-30 | Richard Wolf Gmbh, 7134 Knittlingen | PROBE FOR COAGULATING BODY TISSUE |
US4016886A (en) | 1974-11-26 | 1977-04-12 | The United States Of America As Represented By The United States Energy Research And Development Administration | Method for localizing heating in tumor tissue |
US4119102A (en) | 1975-07-11 | 1978-10-10 | Leveen Harry H | Radio frequency treatment of tumors while inducing hypotension |
US4185618A (en) * | 1976-01-05 | 1980-01-29 | Population Research, Inc. | Promotion of fibrous tissue growth in fallopian tubes for female sterilization |
FR2421628A1 (en) | 1977-04-08 | 1979-11-02 | Cgr Mev | LOCALIZED HEATING DEVICE USING VERY HIGH FREQUENCY ELECTROMAGNETIC WAVES, FOR MEDICAL APPLICATIONS |
US4154246A (en) | 1977-07-25 | 1979-05-15 | Leveen Harry H | Field intensification in radio frequency thermotherapy |
US4160446A (en) * | 1977-08-12 | 1979-07-10 | Abcor, Inc. | Apparatus for and method of sterilization by the delivery of tubal-occluding polymer |
US4346715A (en) | 1978-07-12 | 1982-08-31 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Hyperthermia heating apparatus |
US4522205A (en) | 1980-09-03 | 1985-06-11 | The University Court Of The University Of Edinburgh | Therapeutic device and method of inducing thrombosis in a blood vessel |
US4436715A (en) * | 1981-09-14 | 1984-03-13 | Kms Fusion, Inc. | Storage and retrieval of singlet oxygen |
US4564011A (en) * | 1982-03-22 | 1986-01-14 | Leon Goldman | Laser optic device and method |
US5370675A (en) * | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
SE437394B (en) * | 1983-05-06 | 1985-02-25 | Oldrich Suchanek | DEVICE BY DORR |
US4854320A (en) * | 1983-10-06 | 1989-08-08 | Laser Surgery Software, Inc. | Laser healing method and apparatus |
US4643185A (en) * | 1984-10-01 | 1987-02-17 | Iolab Corporation | Intraocular lens insertion guide |
EP0189329A3 (en) | 1985-01-25 | 1987-06-03 | Robert E. Fischell | A tunneling catheter system for transluminal arterial angioplasty |
DE3516830A1 (en) | 1985-05-10 | 1986-11-13 | Max Dr. 8520 Erlangen Hubmann | CATHETER |
US4660571A (en) | 1985-07-18 | 1987-04-28 | Cordis Corporation | Percutaneous lead having radially adjustable electrode |
US4699147A (en) | 1985-09-25 | 1987-10-13 | Cordis Corporation | Intraventricular multielectrode cardial mapping probe and method for using same |
AT385894B (en) | 1985-10-04 | 1988-05-25 | Basem Dr Nashef | TUBULAR PROBE |
US4700701A (en) | 1985-10-23 | 1987-10-20 | Montaldi David H | Sterilization method and apparatus |
US4643186A (en) | 1985-10-30 | 1987-02-17 | Rca Corporation | Percutaneous transluminal microwave catheter angioplasty |
US4664120A (en) | 1986-01-22 | 1987-05-12 | Cordis Corporation | Adjustable isodiametric atrial-ventricular pervenous lead |
IL78755A0 (en) | 1986-05-12 | 1986-08-31 | Biodan Medical Systems Ltd | Applicator for insertion into a body opening for medical purposes |
US4709698A (en) | 1986-05-14 | 1987-12-01 | Thomas J. Fogarty | Heatable dilation catheter |
US5215103A (en) | 1986-11-14 | 1993-06-01 | Desai Jawahar M | Catheter for mapping and ablation and method therefor |
US5231995A (en) | 1986-11-14 | 1993-08-03 | Desai Jawahar M | Method for catheter mapping and ablation |
US4765331A (en) | 1987-02-10 | 1988-08-23 | Circon Corporation | Electrosurgical device with treatment arc of less than 360 degrees |
US4807620A (en) | 1987-05-22 | 1989-02-28 | Advanced Interventional Systems, Inc. | Apparatus for thermal angioplasty |
SE8800019D0 (en) | 1988-01-07 | 1988-01-07 | Knut Olof Edhag | FOR CARDIALLY DEFIBLATION USED INTRAVASCULES ELECTRO CABLE |
US4852567A (en) * | 1988-01-21 | 1989-08-01 | C. R. Bard, Inc. | Laser tipped catheter |
JPH0240054A (en) * | 1988-07-29 | 1990-02-08 | Fuji Heavy Ind Ltd | Air-fuel ratio control device for internal combustion engine for vehicle |
US4966597A (en) | 1988-11-04 | 1990-10-30 | Cosman Eric R | Thermometric cardiac tissue ablation electrode with ultra-sensitive temperature detection |
US4945912A (en) | 1988-11-25 | 1990-08-07 | Sensor Electronics, Inc. | Catheter with radiofrequency heating applicator |
US5779698A (en) * | 1989-01-18 | 1998-07-14 | Applied Medical Resources Corporation | Angioplasty catheter system and method for making same |
US4979948A (en) | 1989-04-13 | 1990-12-25 | Purdue Research Foundation | Method and apparatus for thermally destroying a layer of an organ |
US5057107A (en) | 1989-04-13 | 1991-10-15 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US5078717A (en) | 1989-04-13 | 1992-01-07 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US4976711A (en) | 1989-04-13 | 1990-12-11 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US5022399A (en) * | 1989-05-10 | 1991-06-11 | Biegeleisen Ken P | Venoscope |
US5100388A (en) * | 1989-09-15 | 1992-03-31 | Interventional Thermodynamics, Inc. | Method and device for thermal ablation of hollow body organs |
US5117828A (en) | 1989-09-25 | 1992-06-02 | Arzco Medical Electronics, Inc. | Expandable esophageal catheter |
US5897551A (en) * | 1990-03-23 | 1999-04-27 | Myriadlase, Inc. | Medical device for applying high energy light and heat for gynecological sterilization procedures |
JP2805377B2 (en) | 1990-04-19 | 1998-09-30 | キヤノン株式会社 | Data communication device |
US5122137A (en) | 1990-04-27 | 1992-06-16 | Boston Scientific Corporation | Temperature controlled rf coagulation |
US5193549A (en) * | 1990-07-11 | 1993-03-16 | Biomedical Dynamics Corporation | Inflatable cuff |
US5188602A (en) | 1990-07-12 | 1993-02-23 | Interventional Thermodynamics, Inc. | Method and device for delivering heat to hollow body organs |
US5100423A (en) | 1990-08-21 | 1992-03-31 | Medical Engineering & Development Institute, Inc. | Ablation catheter |
US5127902A (en) * | 1990-09-05 | 1992-07-07 | Medical Innovative Technologies R&D Limited Partnership | Apparatus and method for precisely controlling the excision of obstructive tissue in a human blood vessel |
US5282845A (en) | 1990-10-01 | 1994-02-01 | Ventritex, Inc. | Multiple electrode deployable lead |
US5053033A (en) | 1990-10-10 | 1991-10-01 | Boston Advanced Technologies, Inc. | Inhibition of restenosis by ultraviolet radiation |
US5178618A (en) | 1991-01-16 | 1993-01-12 | Brigham And Womens Hospital | Method and device for recanalization of a body passageway |
US5156151A (en) | 1991-02-15 | 1992-10-20 | Cardiac Pathways Corporation | Endocardial mapping and ablation system and catheter probe |
CA2061220A1 (en) | 1991-02-15 | 1992-08-16 | Mir A. Imran | Endocardial catheter for defibrillation, cardioversion and pacing, and a system and method utilizing the same |
US5465717A (en) | 1991-02-15 | 1995-11-14 | Cardiac Pathways Corporation | Apparatus and Method for ventricular mapping and ablation |
US5242438A (en) | 1991-04-22 | 1993-09-07 | Trimedyne, Inc. | Method and apparatus for treating a body site with laterally directed laser radiation |
US5275610A (en) | 1991-05-13 | 1994-01-04 | Cook Incorporated | Surgical retractors and method of use |
US5255678A (en) | 1991-06-21 | 1993-10-26 | Ecole Polytechnique | Mapping electrode balloon |
US5383917A (en) | 1991-07-05 | 1995-01-24 | Jawahar M. Desai | Device and method for multi-phase radio-frequency ablation |
US5795325A (en) * | 1991-07-16 | 1998-08-18 | Heartport, Inc. | Methods and apparatus for anchoring an occluding member |
US5246436A (en) | 1991-12-18 | 1993-09-21 | Alcon Surgical, Inc. | Midinfrared laser tissue ablater |
US6210402B1 (en) | 1995-11-22 | 2001-04-03 | Arthrocare Corporation | Methods for electrosurgical dermatological treatment |
US5263493A (en) | 1992-02-24 | 1993-11-23 | Boaz Avitall | Deflectable loop electrode array mapping and ablation catheter for cardiac chambers |
US5277201A (en) * | 1992-05-01 | 1994-01-11 | Vesta Medical, Inc. | Endometrial ablation apparatus and method |
US5411025A (en) | 1992-06-30 | 1995-05-02 | Cordis Webster, Inc. | Cardiovascular catheter with laterally stable basket-shaped electrode array |
US5782239A (en) * | 1992-06-30 | 1998-07-21 | Cordis Webster, Inc. | Unique electrode configurations for cardiovascular electrode catheter with built-in deflection method and central puller wire |
US5257634A (en) * | 1992-07-16 | 1993-11-02 | Angeion Corporation | Low impedence defibrillation catheter electrode |
US5293869A (en) | 1992-09-25 | 1994-03-15 | Ep Technologies, Inc. | Cardiac probe with dynamic support for maintaining constant surface contact during heart systole and diastole |
WO1994007446A1 (en) | 1992-10-05 | 1994-04-14 | Boston Scientific Corporation | Device and method for heating tissue |
US5545161A (en) | 1992-12-01 | 1996-08-13 | Cardiac Pathways Corporation | Catheter for RF ablation having cooled electrode with electrically insulated sleeve |
US6620188B1 (en) * | 1998-08-24 | 2003-09-16 | Radiant Medical, Inc. | Methods and apparatus for regional and whole body temperature modification |
WO1994021170A1 (en) * | 1993-03-16 | 1994-09-29 | Ep Technologies, Inc. | Flexible circuit assemblies employing ribbon cable |
US5405322A (en) | 1993-08-12 | 1995-04-11 | Boston Scientific Corporation | Method for treating aneurysms with a thermal source |
US5445608A (en) | 1993-08-16 | 1995-08-29 | James C. Chen | Method and apparatus for providing light-activated therapy |
US5409000A (en) | 1993-09-14 | 1995-04-25 | Cardiac Pathways Corporation | Endocardial mapping and ablation system utilizing separately controlled steerable ablation catheter with ultrasonic imaging capabilities and method |
US5881727A (en) * | 1993-10-14 | 1999-03-16 | Ep Technologies, Inc. | Integrated cardiac mapping and ablation probe |
WO1995010322A1 (en) | 1993-10-15 | 1995-04-20 | Ep Technologies, Inc. | Creating complex lesion patterns in body tissue |
WO1995010236A1 (en) * | 1993-10-15 | 1995-04-20 | Ep Technologies, Inc. | System for making long thin lesions |
US5683384A (en) * | 1993-11-08 | 1997-11-04 | Zomed | Multiple antenna ablation apparatus |
US5472441A (en) * | 1993-11-08 | 1995-12-05 | Zomed International | Device for treating cancer and non-malignant tumors and methods |
JPH09507645A (en) | 1994-01-18 | 1997-08-05 | エンドバスキュラー・インコーポレイテッド | Vein ligation device and vein ligation method |
US5437664A (en) | 1994-01-18 | 1995-08-01 | Endovascular, Inc. | Apparatus and method for venous ligation |
US5423815A (en) | 1994-01-25 | 1995-06-13 | Fugo; Richard J. | Method of ocular refractive surgery |
US5458596A (en) | 1994-05-06 | 1995-10-17 | Dorsal Orthopedic Corporation | Method and apparatus for controlled contraction of soft tissue |
US5505730A (en) | 1994-06-24 | 1996-04-09 | Stuart D. Edwards | Thin layer ablation apparatus |
US6572609B1 (en) * | 1999-07-14 | 2003-06-03 | Cardiofocus, Inc. | Phototherapeutic waveguide apparatus |
US5562657A (en) | 1994-09-19 | 1996-10-08 | Griffin; Stephen E. | Side fire laser catheter method and apparatus |
US5531739A (en) * | 1994-09-23 | 1996-07-02 | Coherent, Inc. | Method of treating veins |
US5885278A (en) * | 1994-10-07 | 1999-03-23 | E.P. Technologies, Inc. | Structures for deploying movable electrode elements |
US5514130A (en) | 1994-10-11 | 1996-05-07 | Dorsal Med International | RF apparatus for controlled depth ablation of soft tissue |
US5722401A (en) * | 1994-10-19 | 1998-03-03 | Cardiac Pathways Corporation | Endocardial mapping and/or ablation catheter probe |
US5766184A (en) * | 1994-11-02 | 1998-06-16 | Olympus Optical Co., Ltd. | Endoscopic treatment tool |
IT1278372B1 (en) * | 1995-02-15 | 1997-11-20 | Sorin Biomedica Cardio Spa | CATHETER, PARTICULARLY FOR THE TREATMENT OF HEART ARRHYTHMIA. |
US5868740A (en) | 1995-03-24 | 1999-02-09 | Board Of Regents-Univ Of Nebraska | Method for volumetric tissue ablation |
EP0766527A1 (en) * | 1995-04-20 | 1997-04-09 | Jawahar M. Desai | Apparatus for cardiac ablation |
US5746737A (en) * | 1995-06-07 | 1998-05-05 | Trimedyne, Inc. | Enclosure for a lasing device |
US6176240B1 (en) | 1995-06-07 | 2001-01-23 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
US6705323B1 (en) * | 1995-06-07 | 2004-03-16 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and methods |
US5709224A (en) * | 1995-06-07 | 1998-01-20 | Radiotherapeutics Corporation | Method and device for permanent vessel occlusion |
US5863290A (en) * | 1995-08-15 | 1999-01-26 | Rita Medical Systems | Multiple antenna ablation apparatus and method |
US5951547A (en) | 1995-08-15 | 1999-09-14 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method |
US6090105A (en) * | 1995-08-15 | 2000-07-18 | Rita Medical Systems, Inc. | Multiple electrode ablation apparatus and method |
US5810804A (en) * | 1995-08-15 | 1998-09-22 | Rita Medical Systems | Multiple antenna ablation apparatus and method with cooling element |
US5947958A (en) | 1995-09-14 | 1999-09-07 | Conceptus, Inc. | Radiation-transmitting sheath and methods for its use |
US5716321A (en) * | 1995-10-10 | 1998-02-10 | Conceptus, Inc. | Method for maintaining separation between a falloposcope and a tubal wall |
US5817092A (en) * | 1995-11-09 | 1998-10-06 | Radio Therapeutics Corporation | Apparatus, system and method for delivering radio frequency energy to a treatment site |
US5695495A (en) * | 1995-11-20 | 1997-12-09 | Ellman; Alan G. | Electrosurgical electrode for sclerotherapy |
US6228082B1 (en) * | 1995-11-22 | 2001-05-08 | Arthrocare Corporation | Systems and methods for electrosurgical treatment of vascular disorders |
US5925038A (en) * | 1996-01-19 | 1999-07-20 | Ep Technologies, Inc. | Expandable-collapsible electrode structures for capacitive coupling to tissue |
US6036687A (en) * | 1996-03-05 | 2000-03-14 | Vnus Medical Technologies, Inc. | Method and apparatus for treating venous insufficiency |
US6139527A (en) | 1996-03-05 | 2000-10-31 | Vnus Medical Technologies, Inc. | Method and apparatus for treating hemorrhoids |
US6033397A (en) * | 1996-03-05 | 2000-03-07 | Vnus Medical Technologies, Inc. | Method and apparatus for treating esophageal varices |
CA2248260C (en) * | 1996-03-05 | 2010-11-16 | Michael D. Laufer | Vascular catheter-based system for heating tissue |
US6152899A (en) | 1996-03-05 | 2000-11-28 | Vnus Medical Technologies, Inc. | Expandable catheter having improved electrode design, and method for applying energy |
US6077257A (en) * | 1996-05-06 | 2000-06-20 | Vidacare, Inc. | Ablation of rectal and other internal body structures |
US5722403A (en) * | 1996-10-28 | 1998-03-03 | Ep Technologies, Inc. | Systems and methods using a porous electrode for ablating and visualizing interior tissue regions |
US5827268A (en) * | 1996-10-30 | 1998-10-27 | Hearten Medical, Inc. | Device for the treatment of patent ductus arteriosus and method of using the device |
US6091995A (en) * | 1996-11-08 | 2000-07-18 | Surx, Inc. | Devices, methods, and systems for shrinking tissues |
US7073504B2 (en) * | 1996-12-18 | 2006-07-11 | Ams Research Corporation | Contraceptive system and method of use |
US5935098A (en) | 1996-12-23 | 1999-08-10 | Conceptus, Inc. | Apparatus and method for accessing and manipulating the uterus |
US6231507B1 (en) * | 1997-06-02 | 2001-05-15 | Vnus Medical Technologies, Inc. | Pressure tourniquet with ultrasound window and method of use |
ATE291889T1 (en) * | 1997-06-05 | 2005-04-15 | Adiana Inc | DEVICE FOR CLOSING THE Fallopian Tubes |
US6042590A (en) * | 1997-06-16 | 2000-03-28 | Novomedics, Llc | Apparatus and methods for fallopian tube occlusion |
US5916235A (en) | 1997-08-13 | 1999-06-29 | The Regents Of The University Of California | Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities |
US6083223A (en) * | 1997-08-28 | 2000-07-04 | Baker; James A. | Methods and apparatus for welding blood vessels |
US6179832B1 (en) * | 1997-09-11 | 2001-01-30 | Vnus Medical Technologies, Inc. | Expandable catheter having two sets of electrodes |
US6200312B1 (en) | 1997-09-11 | 2001-03-13 | Vnus Medical Technologies, Inc. | Expandable vein ligator catheter having multiple electrode leads |
US6401719B1 (en) * | 1997-09-11 | 2002-06-11 | Vnus Medical Technologies, Inc. | Method of ligating hollow anatomical structures |
US6258084B1 (en) | 1997-09-11 | 2001-07-10 | Vnus Medical Technologies, Inc. | Method for applying energy to biological tissue including the use of tumescent tissue compression |
US6014589A (en) * | 1997-11-12 | 2000-01-11 | Vnus Medical Technologies, Inc. | Catheter having expandable electrodes and adjustable stent |
US7070607B2 (en) * | 1998-01-27 | 2006-07-04 | The Regents Of The University Of California | Bioabsorbable polymeric implants and a method of using the same to create occlusions |
US6517534B1 (en) * | 1998-02-11 | 2003-02-11 | Cosman Company, Inc. | Peri-urethral ablation |
US6322559B1 (en) * | 1998-07-06 | 2001-11-27 | Vnus Medical Technologies, Inc. | Electrode catheter having coil structure |
US6033098A (en) * | 1998-07-30 | 2000-03-07 | Nsi Enterprises Inc. | Bar hanger clip |
US6036689A (en) * | 1998-09-24 | 2000-03-14 | Tu; Lily Chen | Ablation device for treating atherosclerotic tissues |
US6398777B1 (en) * | 1999-02-01 | 2002-06-04 | Luis Navarro | Endovascular laser device and treatment of varicose veins |
US6200332B1 (en) * | 1999-07-09 | 2001-03-13 | Ceramoptec Industries, Inc. | Device and method for underskin laser treatments |
WO2001005306A1 (en) * | 1999-07-19 | 2001-01-25 | Epicor, Inc. | Apparatus and method for ablating tissue |
US6709667B1 (en) * | 1999-08-23 | 2004-03-23 | Conceptus, Inc. | Deployment actuation system for intrafallopian contraception |
US6666858B2 (en) * | 2001-04-12 | 2003-12-23 | Scimed Life Systems, Inc. | Cryo balloon for atrial ablation |
WO2005065079A2 (en) * | 2003-11-10 | 2005-07-21 | Angiotech International Ag | Medical implants and fibrosis-inducing agents |
US7396755B2 (en) * | 2005-05-11 | 2008-07-08 | Texas Instruments Incorporated | Process and integration scheme for a high sidewall coverage ultra-thin metal seed layer |
US20070056591A1 (en) * | 2005-09-15 | 2007-03-15 | Mcswain Hugh | Fallopian tube occlusion devices and methods |
-
1997
- 1997-09-11 US US08/927,251 patent/US6200312B1/en not_active Expired - Lifetime
- 1997-10-26 US US08/958,766 patent/US6165172A/en not_active Expired - Lifetime
-
1998
- 1998-09-11 KR KR10-2000-7002611A patent/KR100451273B1/en not_active IP Right Cessation
-
1999
- 1999-03-10 US US09/267,756 patent/US6237606B1/en not_active Expired - Lifetime
-
2000
- 2000-03-09 IL IL135008A patent/IL135008A/en not_active IP Right Cessation
-
2001
- 2001-05-25 US US09/866,517 patent/US6769433B2/en not_active Expired - Lifetime
-
2004
- 2004-07-28 US US10/900,563 patent/US7406970B2/en not_active Expired - Fee Related
-
2008
- 2008-05-23 US US12/126,727 patent/US7901402B2/en not_active Expired - Fee Related
- 2008-06-16 US US12/140,219 patent/US20080249519A1/en not_active Abandoned
- 2008-07-28 US US12/181,277 patent/US8679110B2/en not_active Expired - Fee Related
- 2008-10-24 US US12/258,358 patent/US8267931B2/en not_active Expired - Fee Related
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7901402B2 (en) | 1997-09-11 | 2011-03-08 | Tyco Healthcare Group, Lp | Expandable catheter having two sets of electrodes |
US8679110B2 (en) | 1997-09-11 | 2014-03-25 | Covidien Lp | Expandable vein ligator catheter having multiple electrode leads, and method |
US20070100329A1 (en) * | 2003-09-30 | 2007-05-03 | Ceramoptec Industries Inc. | Method for treatment of varices |
US8257411B2 (en) * | 2003-09-30 | 2012-09-04 | Biolitec Pharma Marketing Ltd | Method for treatment of varices |
US20060189967A1 (en) * | 2005-02-21 | 2006-08-24 | Leonardo Masotti | Device, a catheter, and a method for the curative treatment of varicose veins |
US20100330896A1 (en) * | 2009-06-25 | 2010-12-30 | Fujitsu Limited | Air conditioning installation and control method |
US9017155B2 (en) * | 2009-06-25 | 2015-04-28 | Fujitsu Limited | Air conditioning installation and control method |
US9241694B2 (en) * | 2013-02-21 | 2016-01-26 | St. Jude Medical Puerto Rico Llc | Bioadhesive delivery systems and methods for vascular closure |
US20140236225A1 (en) * | 2013-02-21 | 2014-08-21 | St. Jude Medical Puerto Rico Llc | Bioadhesive delivery systems and methods for vascular closure |
US20150157851A1 (en) * | 2013-12-05 | 2015-06-11 | Advanced Neuromodulation Systems, Inc. | Medical leads with segmented electrodes and methods of fabrication thereof |
US9370653B2 (en) * | 2013-12-05 | 2016-06-21 | Advanced Neuromodulation Systems, Inc. | Medical leads with segmented electrodes and methods of fabrication thereof |
US20160263370A1 (en) * | 2013-12-05 | 2016-09-15 | Advanced Neuromodulation Systems, Inc. | Medical leads with segmented electrodes and methods of fabrication thereof |
US10226619B2 (en) * | 2013-12-05 | 2019-03-12 | Advanced Neuromodulation Systems, Inc. | Medical leads with segmented electrodes and methods of fabrication thereof |
US11033733B2 (en) * | 2013-12-05 | 2021-06-15 | Advanced Neuromodulation Systems, Inc. | Medical leads with segmented electrodes and methods of fabrication thereof |
US20170128697A1 (en) * | 2015-11-06 | 2017-05-11 | Kardium Inc. | Medical device systems and methods including safety release, lumen fluid-providing mechanisms, or both |
US11147947B2 (en) * | 2015-11-06 | 2021-10-19 | Kardium Inc. | Medical device systems and methods including safety release, lumen fluid-providing mechanisms, or both |
Also Published As
Publication number | Publication date |
---|---|
US20040267258A1 (en) | 2004-12-30 |
US20090137998A1 (en) | 2009-05-28 |
US6165172A (en) | 2000-12-26 |
KR100451273B1 (en) | 2004-10-06 |
US7901402B2 (en) | 2011-03-08 |
KR20010030589A (en) | 2001-04-16 |
US8679110B2 (en) | 2014-03-25 |
US6237606B1 (en) | 2001-05-29 |
US20090005775A1 (en) | 2009-01-01 |
US8267931B2 (en) | 2012-09-18 |
IL135008A (en) | 2007-10-31 |
US20020007181A1 (en) | 2002-01-17 |
US6200312B1 (en) | 2001-03-13 |
US6769433B2 (en) | 2004-08-03 |
US20090054884A1 (en) | 2009-02-26 |
US7406970B2 (en) | 2008-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7396355B2 (en) | Method and apparatus for applying energy to biological tissue including the use of tumescent tissue compression | |
US20080249519A1 (en) | Method and apparatus for applying energy to biological tissue including the use of tumescent tissue compression | |
US6682526B1 (en) | Expandable catheter having two sets of electrodes, and method of use | |
US6401719B1 (en) | Method of ligating hollow anatomical structures | |
US6981972B1 (en) | Apparatus for treating venous insufficiency using directionally applied energy | |
EP0969773B1 (en) | Apparatus for treating venous insufficiency using directionally applied energy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: VNUS MEDICAL TECHNOLOGIES, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GOLDMAN, MITCHELL P.;WEISS, ROBERT A.;ZIKORUS, ARTHUR W.;AND OTHERS;REEL/FRAME:023379/0827;SIGNING DATES FROM 19990420 TO 19990505 Owner name: VNUS MEDICAL TECHNOLOGIES, LLC, MASSACHUSETTS Free format text: CHANGE OF NAME;ASSIGNOR:VNUS MEDICAL TECHNOLOGIES, INC.;REEL/FRAME:023379/0892 Effective date: 20090626 Owner name: TYCO HEALTHCARE GROUP, LP, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VNUS MEDICAL TECHNOLOGIES, LLC;REEL/FRAME:023379/0901 Effective date: 20090626 Owner name: VNUS MEDICAL TECHNOLOGIES, LLC,MASSACHUSETTS Free format text: CHANGE OF NAME;ASSIGNOR:VNUS MEDICAL TECHNOLOGIES, INC.;REEL/FRAME:023379/0892 Effective date: 20090626 Owner name: TYCO HEALTHCARE GROUP, LP,MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VNUS MEDICAL TECHNOLOGIES, LLC;REEL/FRAME:023379/0901 Effective date: 20090626 |
|
AS | Assignment |
Owner name: VNUS MEDICAL TECHNOLOGIES, LLC,MASSACHUSETTS Free format text: CHANGE OF NAME;ASSIGNOR:VNUS MEDICAL TECHNOLOGIES, INC.;REEL/FRAME:023928/0932 Effective date: 20090626 Owner name: TYCO HEALTHCARE GROUP, LP,MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VNUS MEDICAL TECHNOLOGIES, LLC;REEL/FRAME:023928/0943 Effective date: 20090626 Owner name: VNUS MEDICAL TECHNOLOGIES, LLC, MASSACHUSETTS Free format text: CHANGE OF NAME;ASSIGNOR:VNUS MEDICAL TECHNOLOGIES, INC.;REEL/FRAME:023928/0932 Effective date: 20090626 Owner name: TYCO HEALTHCARE GROUP, LP, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VNUS MEDICAL TECHNOLOGIES, LLC;REEL/FRAME:023928/0943 Effective date: 20090626 |
|
STCB | Information on status: application discontinuation |
Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION |